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Abstract
The advent of high-throughput next-generation sequencing technologies has transformed our
understanding of cell biology and human disease. It is now common for investigators to study human cell
populations by profiling the transcriptomes for thousands of single cells using single-cell RNA sequencing
(scRNA-seq) technologies. In addition, recent advances in spatially resolved transcriptomics (SRT)
technologies have enabled gene expression profiling with spatial information in tissues. Knowledge of the
relative locations of different cells in a tissue is critical for understanding disease pathology because
spatial information helps in understanding how the gene expression of a cell is influenced by its
surrounding environment and how neighboring regions interact at the gene expression level. In order to
take full advantage of the multi-modality information when analyzing scRNA-seq and SRT data, new
methods are demanded for the following challenges: (1) how to identify cell types for scRNA-seq data
with closely related cell types or low sequencing depths? (2) how to jointly model gene expression, spatial
location, and histology in SRT data analysis? (3) how to increase gene expression resolution in SRT to
study detailed tissue structure? In this dissertation, I seek to address these various challenges and
difficulties associated with scRNA-seq and SRT data analyses. To address challenge (1), I developed
ItClust, a supervised machine learning method that takes advantage of cell-type-specific gene expression
information learned from a well-labeled source dataset, to help cluster and classify cell types on newly
generated target data. To address challenge (2), I developed SpaGCN, a graph convolutional network
approach that integrates gene expression, spatial location and histology to identify spatial domains and
spatially variable genes in SRT data analysis. Lastly, to address challenge (3), I developed TESLA, a
machine learning framework that enhances gene expression resolution in SRT and further performs multilevel tissue annotation with pixel-level resolution. I validated the utility of each of these approaches using
experimentally validated cell type labels and independent pathologists’ annotation. I also demonstrated
real use cases for these methods in deciphering tumor microenvironment in various cancer types.
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ABSTRACT

MACHINE LEARNING METHODS FOR THE ANALYSIS OF SINGLE-CELL AND
SPATIALLY RESOLVED TRANSCRIPTOMICS DATA
Jian Hu
Mingyao Li
The advent of high-throughput next-generation sequencing technologies has
transformed our understanding of cell biology and human disease. It is now common for
investigators to study human cell populations by profiling the transcriptomes for
thousands of single cells using single-cell RNA sequencing (scRNA-seq) technologies. In
addition, recent advances in spatially resolved transcriptomics (SRT) technologies have
enabled gene expression profiling with spatial information in tissues. Knowledge of the
relative locations of different cells in a tissue is critical for understanding disease
pathology because spatial information helps in understanding how the gene expression
of a cell is influenced by its surrounding environment and how neighboring regions
interact at the gene expression level. To take full advantage of the multi-modality
information when analyzing scRNA-seq and SRT data, new methods are demanded for
the following challenges: (1) how to identify cell types for scRNA-seq data with closely
related cell types or low sequencing depths? (2) how to jointly model gene expression,
spatial location, and histology in SRT data analysis? (3) how to increase gene expression
resolution in SRT to study detailed tissue structure? In this dissertation, I seek to
address these various challenges and difficulties associated with scRNA-seq and SRT
data analyses. To address challenge (1), I developed ItClust, a supervised machine
learning method that takes advantage of cell-type-specific gene expression information
v

learned from a well-labeled source dataset, to help cluster and classify cell types on
newly generated target data. To address challenge (2), I developed SpaGCN, a graph
convolutional network approach that integrates gene expression, spatial location and
histology to identify spatial domains and spatially variable genes in SRT data analysis.
Lastly, to address challenge (3), I developed TESLA, a machine learning framework that
enhances gene expression resolution in SRT and further performs multi-level tissue
annotation with pixel-level resolution. I validated the utility of each of these approaches
using experimentally validated cell type labels and independent pathologists’ annotation.
I also demonstrated real use cases for these methods in deciphering tumor
microenvironment in various cancer types.
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Chapter 1: Introduction

1.1. Importance of RNA
The central dogma of molecular biology, formulated in the 20th century after the
discovery of DNA, explains the flow of genetic information stored in DNA transcribed
into RNA and then translated into proteins, which ultimately characterizes the
phenotype of an organism. RNA serves as the intermediate messenger between DNA and
its encoded protein products are called coding RNA (cRNA). Evidence suggests that only
less than 3% of the mammalian genome is transcribed into cRNA, while most of the
RNA, termed noncoding RNA (ncRNA), has no protein-coding capacity[1]. ncRNA is
divided into two groups: small regulatory RNA with size < 200 nucleotides (e.g., miRNA,
piRNA) and long ncRNAs with size >= 200 nucleotides (e.g., lincRNA, NAT). Both
ncRNA groups play regulatory roles in gene expression and genome architecture,
controlling when and how the genetic information is expressed.
RNA has gained increasing attention in understanding human diseases. Compared to
DNA, which is nearly identical for all cells from the same organism, RNA is more
dynamic and can reveal splicing variants, gene fusions, mutations in addition to
differential gene expression, providing a more comprehensive picture of cell growth and
differentiation. Although protein is more directly involved in many biological processes
than RNA, studies have shown significant correlations between the expression of RNAs
and their coded proteins [2]. Therefore, understanding the role of RNA in disease
progresses is critical for deciphering the molecular mechanisms of disease initiation,
development, progression, and metastasis. As sequencing techniques to measure the
expression of RNA has rapidly evolved and been commercialized, it quickly became a
routine research tool to study human diseases in many laboratories.
1

Many breakthroughs arising from discoveries of the role of RNA in disease mechanisms
have led to important clinical applications in cancer therapy. For example, RNA
interference (RNAi) refers to a member of small regulatory RNA that regulates the
mechanism for gene silencing. This mechanism possesses an uncanny ability to target
cancer-related genes. A large number of gene products involved in tumorigenesis have
been utilized as targets in RNAi-based therapy [1]. Another more up-to-date example is
the Pfizer-BioNTech COVID-19 vaccine. Rather than directly delivering copies of the
viral spike proteins into human body, it functions by delivering mRNA that is used to
translate these proteins.

1.2. RNA-sequencing Techniques
RNA-sequencing is a technique that can profile the quantity and sequences of RNA in a
sample using next-generation sequencing (NGS). Since the first high-throughput
sequencing platform appeared in 2005 [3], this technique has been continuously
developed with higher efficiency and lower cost. It has been widely used during the past
few decades and has ushered transcriptome analysis into a new era with a more
prosperous and less biased view of the transcriptome than was possible with the previous
microarray-based methods [4].
The wet-lab workflow for RNA-sequencing begins with RNA extraction, followed by
mRNA purification and enriching, cDNA synthesis, and preparation of an adaptorligated sequencing library. The library is then sequenced to a read depth of 10–30
million reads per sample on a high-throughput platform. The next steps are
computational, including aligning sequencing reads to a known transcriptome reference,
quantifying control to filter out low-quality reads, normalizing between samples, and
finally, statistical modeling for various goals.
2

In earlier decades, investigators had to sequence RNA in bulk, with each sequencing unit
containing multiple cells. The bulk measurements were often averages of cells from
multiple cell types, which can significantly confound the downstream analyses, such as
in the identification of cell-type heterogeneity, differentially expressed genes, and
expression of quantitative trait loci. The variability in cell-type composition also makes it
difficult to study rare cell subpopulations since their expression dynamics cannot be
disentangled from the expression of more common cell types, which dominate the bulk
measurements. These problems that arise in bulk RNA sequencing were largely
remedied with the proliferation of single-cell RNA-sequencing (scRNA-seq) technology.
ScRNA-seq, as indicated by its name, allows investigators to study RNA gene expression
at single-cell resolution. Single cell is the basic structural, biological, and functional unit
of organisms. Every single cell is unique with distinct somatic alterations, transcriptional
regulations, and epigenetic modifications, and these differences between cells are most
likely reflected at the RNA level. Given the extraordinary transcriptional diversity at the
single-cell scale, scRNA-seq technology rapidly became one of the most valuable and
extensively used tool in cancer molecular biology after its advent in 2009 [5]. With this
new technology, investigators can now dissect transcriptome heterogeneity, discover rare
and novel cell types, explore the dynamics of developmental biological processes, and
identify gene regulatory mechanisms at higher accuracy than ever before.
However, scRNA-seq has its own limitations. Owing to the low amount of starting
material, scRNA-seq has low capture efficiency and high dropout rates [6]. In contrast to
bulk RNA sequencing, data produced using scRNA-seq usually contain a much smaller
number of cells and has more technical noise and biological variation, raising substantial
challenges for computational analysis. A variety of existing tools designed to conduct
bulk RNA sequencing data analyses cannot be directly applied to scRNA-seq data. Of
3

note, due to the above-mentioned limitations, scRNA -seq does completely become an
advanced alternative solution compared to bulk RNA sequencing. It serves more as a
complementary tool along with bulk sequencing to better study the tissue. In studies that
generate both bulk and scRNA-seq data, the scRNA-seq data are often used as a
reference for cell-type deconvolution in the bulk data.

1.3. Applications of Single-cell Genomics
RNA-sequencing is a technique that can profile the quantity and sequences of RNA in a
sample using next-generation sequencing (NGS). Since the first high-throughput
sequencing platform appeared in 2005, this technique has been continuously developed
with higher efficiency. scRNA-seq has been most widely used to study human disease
because of its maturity and has profoundly advanced our views of transcriptional
complexity. Here, I briefly discuss some common tasks in data analysis and available
methods for each of these tasks.
1.3.1. Cell Type Classification
Cell type is defined as a set of cells that share similar gene expression signatures,
morphology, and functions. Cells from different cell types often assume specific roles by
collectively contributing to the overall functions of a tissue or organ. Knowledge of cell
types can reveal cellular heterogeneity across tissues, developmental stages, and
organisms, and improve our understanding of cellular and gene function in health and
disease.
In earlier years, the classification of a specific cell type is often done using microscopy.
Recent developments in scRNA-seq have facilitated the classification of cell types based
on shared gene expression signatures. The transcriptomic analysis at the single-cell level
4

is highly informative in improving the accuracy of cell type classification and has led to
the discovery of many novel cell types in many organisms and species. Great efforts have
been made to develop analysis tools for cell-type classification in scRNA-seq analysis.
Early developed algorithms for this task, for example, Louvain’s method [7], SIMLR [8],
SC3 [9], are mostly unsupervised. They separate the cells into unidentified clusters and
then relie on manual efforts to assign the cell-type identity to each group by checking
cell-type marker genes. As more and more well-annotated scRNA-seq datasets are
becoming available, many state-of-the-art methods start to utilize information in these
datasets to aid cell type identification in new data. For example, methods such as scmap
[10], scANVI [11], Moana [12] , and Seurat [13] can learn the cell-type-specific gene
expression signature from the training data and automatically label the cell types for
cells in the testing data. Most of these methods’ performance is vulnerable to low-quality
training data, and they often perform poorly for novel cell types. In order to solve these
problems, I developed ItClust [14] for cell-type classification. More details are described
in Chapter 2.
1.3.2. Differential Expression and Gene Set Enrichment Analysis
Detecting differentially expressed (DE) genes between different cell populations is one of
the most common tasks in scRNA-seq analysis. DE genes are identified by comparing
cells under different experimental conditions, for example stimulated versus nonstimulated, mutant versus wild-type, or between different time points. By further
examining the functions of these DE genes, investigators can determine the root cause of
phenotypic differences observed under different conditions. Some algorithms developed
for DE analysis include DESingle [15], DECENT [16] and SCDE [17]. Seurat also has DE
analysis integrated into its analysis pipeline. Additionally, some methods, like PennDiff
[18], are developed to detect differential alternative splicing and transcription. Gene set
5

enrichment analysis (GSE)analysis is often conducted as a separate step after DE
analysis. DE genes are used as input to GSE analysis to check their participation in
common biological processes to further facilitate the interpretation of results. Most
existing GSE analysis methods developed for bulk sequencing data, including PAGE[19],
CAMERA[20], can also be applied to scRNA-seq analysis.
1.3.3. Reconstruction of Cell Trajectory and Pseudo-time Estimation
Cellular processes, including cell differentiation and cell maturation, are dynamic. Cell
types can be modified not necessarily as a discrete identity but rather as a continuously,
gradually shifting identity, especially for cells from developing tissues. The dynamics of
cellular processes cannot be well described by discrete analysis like clustering. Therefore,
methods such as single-cell trajectory reconstruction and pseudo-time estimation have
emerged. These methods order single cells onto a one-dimensional space, indicating how
far these cells are along a dynamic process of interest. Although the collection of timeseries data from exactly the same cells is still impossible, results from pseudo-time
analysis can help uncover the latent temporal information such as cell differentiation
and cell cycle. Existing methods such as Monocle2 [21], TSCAN [22], and Slingshot [23]
have been shown to have good performance at this task.

1.4. Spatially Resolved Transcriptomics
The tissues in our body consist of diverse cell types with each cell type specialized to
carry out a particular function. The behavior of a cell is influenced by its surrounding
environment within a tissue. Knowledge of the relative locations of different cells in a
tissue is critical for understanding the spatial organization of cell types and disease
pathology. Although scRNA-seq has made it possible to characterize cell types and states
and to study cellular mechanisms at an unprecedented resolution, the lack of physical
6

relationship among cells has hindered the study of cell-cell interactions within tissue
context. The maintenance of spatial context is critical for uncovering the complex
transcriptional architecture of heterogenous tissues; for example, within a tumor, several
subpopulations of cancer cells constituting a tumor can vastly differ from each other in
their gene expression profiles and cellular properties due to residing in distinct tumor
microenvironments.
Recent technology advances in spatially resolved transcriptomics (SRT) have enabled
gene expression profiling with location information in tissues. Popular experimental
methods to generate SRT data can be broadly classified into two categories. The first
category is image-based in situ transcriptomics, termed single-molecule fluorescent in
situ hybridization (smFISH) [24-27], which detects several mRNA transcripts
simultaneously at subcellular resolution. Later efforts such as seqFISH [28, 29],
seqFISH+ [30], and MERFISH [31] have substantially increased the number of
detectable mRNA species with multiplexed smFISH. With these new technologies, the
expression level for hundreds to thousands of genes can be simultaneously measured
with subcellular resolution in a single cell. The second category is based on spatial
barcoding followed by next-generation sequencing-based techniques, such as Spatial
Transcriptomics (ST) [32], SLIDE-seq [33], SLIDE-seq2 [34], and high-definition spatial
transcriptomics (HDST) [35], which measure the expression level for thousands of genes
in captured locations, referred to as spots. Recently, 10x Genomics commercialized the
ST technology in their Visium Spatial Gene Expression platform, which reduced the
diameter size from 100 µm per spot in ST to 55 µm. Although SLIDE-seq and HDST have
higher resolution than ST and Visium, the number of unique molecules detected per spot
by these technologies is lower than ST and Visium.
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Sequencing-based methods for SRT are often complemented by high-resolution
hematoxylin and eosin (H&E) stained histology images, which are invaluable for
examining cellular morphology and how it changes over embryonic development or
disease progression. Since sequencing-based technologies intend to capture mRNAs
without the need to prespecify what genes to include, they can characterize both known
and unknown molecular features in a tissue section. The combined gene expression and
histological features within spatial context allow researchers to access additional
dimensions of information helping to inform developmental trajectory and the origin
and progression of complex disease. Using sequencing based SRT technologies, Asp et al.
profiled spatiotemporal gene expression patterns in developing human heart [36];
Maniatis et al. studied the progression of amyotrophic lateral sclerosis [37]; and Chen et
al. identified transcriptional changes in tissue domains surrounding amyloid plaques in
Alzheimer’s disease [38]. Sequencing-based SRT has also been employed to study
various types of cancer, including prostate cancer [39], melanoma [40], breast cancer
[41], pancreatic ductal adenocarcinomas [42], and squamous cell carcinoma [43].
Due to the profound impact of SRT in advancing our views of transcriptional complexity,
Nature Methods recently selected SRT as Method of the Year 2020 [44]. Many of the
published studies on SRT used computational tools developed for scRNA-seq. However,
SRT data have different properties from those from scRNA-seq e.g., sequencing-based
SRT technologies often measure the transcriptomes of multiple cells per spot, and the
gene expression levels of neighboring spots and cells are correlated. However, the spatial
dependency of gene expression and the histological features are not modeled by tools
that are developed for scRNA-seq. To fully harness the added spatial and histology
information in SRT, new methods that can connect gene expression features with spatial
location and histological features are needed.
8

1.5. Applications in Spatially Resolved Transcriptomics
1.5.1. Spatial Clustering
In SRT studies, an important step is to cluster the spots and identify spatial domains,
i.e., regions that are spatially coherent in both gene expression and histology. Identifying
spatial domains requires methods that can jointly consider gene expression, spatial
location, and histology. Traditional clustering methods used in scRNA-seq analysis,
mentioned in 1.3.1, only take gene expression data as input, but do not incorporate
spatial location and histology information. As such, the resulting clusters may not be
contiguous due to the lack of consideration of spatial and histology constraints during
clustering36. Several new spatial clustering methods have been developed to account for
spatial dependency of gene expression [45-47].
1.5.2. Identification of Spatially Variable Genes
Another important task in SRT data analysis is to identify spatially variable genes
(SVGs), i.e., genes that show spatial expression variation across a tissue section. Methods
for SVG detection fall into two categories, where the first category aims to detect SVGs
without the consideration of spatial domains, and the second category detects SVGs with
the guidance of spatial domains identified from a spatial clustering algorithm. Recently
developed methods, such as Trendsceek [48], SpatialDE [49], SPARK [50], belong to the
first category, whereas SpaGCN [47] belongs to the second category. Consideration of
spatial domains in SVG detection will help ensure the detected genes show enriched
expression pattern in a spatial domain. These genes can serve as landmarks in helping to
reconstruct the spatial locations of cells in scRNA-seq [13, 51].
1.5.3. Cell-type Deconvolution in Spatial Transcriptomics Spots
9

Although sequencing-based SRT technologies such as ST and Visium allow an unbiased
survey of the transcriptome, the primary technological limitation of ST and Visium is the
lack of single-cell resolution. The first-generation ST microarrays consist of ~1,000
spots, each with a diameter of 100µm and covering tens of cells. In the recent Visium
platform, the throughput is increased to ~5,000 spots and the diameter of each spot is
reduced to 55µm. Depending on tissue type, the number of cells per spot in Visium is
about 1-10. Thus, the observed gene expression at each spot in ST and Visium may stem
from a heterogeneous set of cells, not all necessarily of the same type. On the other hand,
scRNA-seq profiles gene expression with single-cell resolution, although with the loss of
spatial location information. Given the complementary information provided by
sequencing-based SRT and scRNA-seq, one can use statistical approaches to integrate
these two data types to infer the spatial locations of different cell types in a tissue. Celltype deconvolution is not a new problem. Indeed, this approach has been employed in
bulk RNA-seq to infer cell-type composition with cell-type-specific gene expression
provided by scRNA-seq [52, 53]. However, traditional deconvolution methods do not
work well for sequencing based SRT data due to the lack of consideration of spatial
dependency of gene expression. More recently, methods designed specifically for
sequencing based SRT data have emerged [54-56].
1.5.4. Enhancement of Gene Expression Resolution
As described earlier, sequencing-based SRT data lack single-cell resolution. While celltype deconvolution algorithms can infer the locations of cell types, the gene expression
measured at each spot is still a mixture from different cells, possibly from different cell
types. There is a need for spatial gene expression methods that address the relatively low
resolution of the technology. Since gene expression in neighboring spots is correlated, it
is possible to borrow information from neighboring spots to increase gene expression
10

resolution. Furthermore, bright field histology images from H&E-stained tissue sections
offer high-resolution information on cell morphology, which can be utilized to enhance
gene expression resolution.
1.5.5. Cell-cell Communications from Gene Expression
Previous gene expression studies have shown that intercellular communication
contributes to organ function and other critical biological processes [57, 58]. After the
locations of cell types are inferred by cell-type deconvolution, it is natural to ask how
different cell types interact and how their interactions are influenced by their spatial
proximity [59]. For example, when two cell types colocalize, cells in one cell type may
secrete a signaling ligand molecule, whereas the other cell type may express a receptor
molecule that recognizes the ligand. Binding of the ligand to the receptor allows the
ligand to transmit a signal and change the molecular behavior of the receiver cell.
Indeed, ligand-receptor pairs have been used to explore communications between cell
types in scRNA-seq [60]. Since the distance that the ligand signal travels is the main
factor that determines the different types of cell-cell signaling, SRT offers richer
information to study cell-cell communications in tissues with spatial structure. Recently,
several methods have been developed to explore cell-cell communications from gene
expression [61, 62].
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Chapter 2: ItClust: Iterative transfer learning with neural network for
clustering and cell type classification in single-cell RNA-seq analysis

2.1. Introduction
Only recently has the single-cell RNA sequencing (scRNA-seq) technology matured.
Emerging scRNA-seq studies have transformed our understanding of cell biology and
human disease. An important step in scRNA-seq analysis is to identify cell populations
or types by clustering [63]. Knowledge in cell types can reveal cellular heterogeneity
across tissues, developmental stages and organisms, and improve our understanding of
cellular and gene function in health and disease. Despite the unprecedented power of
scRNA-seq, the high-dimensionality and inherited high level of technical noise are major
hurdles for cell type identification. Popular scRNA-seq clustering methods such as
Louvain’s method [7], SIMLR [8], and SC3 [9] may perform poorly for data with closely
related cell types or low sequencing depths. Although denoising methods such as SAVER
[64] and DCA [65] can provide more accurate gene expression estimates and help
clustering, these methods are unsupervised, and cannot utilize cell type-specific gene
expression information.
Since a large amount of well-annotated scRNA-seq datasets are already available, many
state-of-the-art methods start to utilize information in these well-annotated datasets to
aid cell type identification in new data. For example, scmap [10] projects cells in a target
dataset to a space determined by highly informative genes selected from a well-labeled
source dataset, and then assigns cell identities for cells in the target data based on their
correlation with average cell type-specific gene expression in the source data. scANVI
[66] is a semi-supervised variant of scVI [67] that annotates cell types in a target dataset
by leveraging any available cell state annotations. Moana [12] trains a support-vector12

machine (SVM) with a linear kernel on principal component analysis (PCA)-transformed
labeled source data, which are subsequently used to cluster cells in the target data.
Seurat 3.0 [68] classifies cells in target data by finding anchor cell pairs between a welllabeled source dataset and the unlabeled target dataset. Both scmap and Moana learn
cell type-specific gene expression information only in the source data, but ignore useful
information in the target data, thus are vulnerable to batch effect between the source and
target data. Although Seurat 3.0 utilizes information both in the source and target data
through the identification of anchor pairs, it does not specifically utilize cell type label
information in the source data.
An ideal approach for cell type identification should be able to utilize cell type-specific
gene expression information both in the well-labeled source data and the unlabeled
target data. Since the source and target data provide different amount of cell typespecific gene expression information, it is desirable to use a data-driven approach to
determine the contribution of each data type in analysis. Transfer learning, a machine
learning method that focuses on storing knowledge gained while solving one problem
and applying it to a different but related problem, suits perfectly for this purpose.
Transfer learning using supervised pre-training was originally proposed by Donahue et
al. [69] in which they showed that features extracted from a deep convolutional network
in a fully supervised fashion for object recognition tasks can be repurposed to novel
generic tasks. Borrowing this idea, we developed ItClust, a supervised machine learning
method that takes advantage of cell type-specific gene expression information learned
from source data, to help cluster and classify cell types on newly generated target data.
Unlike the unsupervised Louvain’s method [7], which requires users to specify
‘resolution’ to determine the number of clusters, ItClust is able to automatically
determine the number of clusters in the target dataset. It is also superior to existing
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supervised classification methods in that cell types that are missing in the source data
can be well separated in the target data.

2.2. Materials and Methods
2.2.1. Motivation for the Use of Transfer Learning
As the scale of scRNA-seq studies continues to grow, more and more data are being
generated. Many studies are multi-year projects in which new data are continuously
generated over time. Repeating clustering and cell type classification analysis every time
when new data are generated is time consuming. To simplify the analysis, it is appealing
to cluster and annotate newly generated cells while utilizing cell type information
learned from analysis of previous data. Transfer learning with supervised pre-training
[69] suits perfectly for this purpose because the previously clustered and annotated cells
can be used to train a supervised model, and the newly generated cells can benefit from
utilizing gene expression features learned from the previous model.
2.2.2. Information Extraction from Source Data Using the Source Network
ItClust requires two input datasets, a source dataset that includes cells with wellannotated cell type labels, and a target dataset that includes cells that need to be
clustered and annotated. ItClust starts from selecting top ℎ highly variable genes from
the target data. Then, it finds the 𝑝 overlapping genes in the source data (𝑝 ≤ ℎ) and
extracts the corresponding gene expression matrix for all 𝑛 cells in the source data. Let
𝑋 ∈ 𝑅!×# be the extracted normalized single-cell gene expression matrix used to train the
source network in which rows correspond to cells and columns correspond to genes.
Since scRNA-seq data are high-dimensional, instead of training directly in the original
data space, we perform dimension reduction by transforming the data using a nonlinear
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mapping function 𝑓$ : 𝑋 → 𝑍, where 𝜃 represents embedding parameters, and 𝑍 ∈ 𝑅!×% is
the latent feature space, with 𝑑 ≪ 𝑝. To parameterize 𝑓$ , we use a stacked autoencoder
and initialize it layer by layer with each layer being a denoising autoencoder trained to
reconstruct the previous layer’s output after random corruption [70]. We use ReLU as
the activation function except for the bottleneck layer and last decoder layer, in which
tanh is used as the activation function. After training each layer by minimizing the leastsquare loss, we concatenate all encoder layers followed by all decoder layers in reverse
layer-wise training order to form a multilayer autoencoder, with a bottleneck layer in the
middle, fine-tuning it to minimize the reconstruction loss. Then, we discard all decoder
layers and use the encoder layers as our initial mapping between raw data and the
dimension-reduced feature space.
Next, we add a clustering layer to the encoder network. Since the source dataset is
labeled and the number of true cell types 𝑘 is known, we use 𝑘 to set the number of
clusters. For each cluster 𝑗 (𝑗 = 1, … , 𝑘), the cluster centroid 𝜇& is determined by the
mean features in the embedding layer based on cells in each cell type. This step assigns
each cell type with an initial cluster and ensures that only cell type-specific gene
expression signatures are captured during the later network optimization process.
2.2.3. Transferring Cell Type Information in the Source Data to the Target Network
Let 𝑋′ ∈ 𝑅'×# be the normalized gene count matrix for the target dataset with 𝑚 cells,
where 𝑝 is a subset of the highly variable genes in the target data that are also present in
the source data. We build a new network using the same structure as the source network.
Rather than randomly initializing the target network, we transfer weights learned from
the source network to the target network as initial values, except for the final clustering
layer. This step ensures that the new network can map the target data to the same feature
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space 𝑅% as done in the source network, that is, 𝑋 ( → 𝑍 ( , where 𝑍 ( ∈ 𝑅'×% . In the next
step, we apply an iterative clustering algorithm on the feature space 𝑍′ [71]. Since cell
type labels for the target dataset are unknown, to get the number of clusters and cluster
centroids, for each cell in the target dataset, we predict its cluster using the source
network, and use the predicted number of clusters and mean features in each predicted
cell cluster as the centroid to initialize the clustering layer. The number of clusters for the
target data is determined by the number of cell types that is present in the source data.
Specifically, ItClust will generate the same number of clustering centroids as the number
of cell types in the source data. These centroids are used to cluster cells in the target data.
If no cells are assigned to a centroid, it will be eliminated.
2.2.4. Fine-tuning of the Target Network
In addition to incorporating information from the source data, it is also necessary to
incorporate unique information that is present in the target data only. To do so, we
iteratively fine-tune the target network to make it more adaptive to the target data.
During fine-tuning, for cell types that are present both in the source and target data,
their cluster centroids will be mainly driven by the source data, and they will shift
slightly to adapt to the target data over iterations. For cell types that are only present in
the source data, none (or only a few) of the cells in the target data will be assigned to
their centroids and we call these centroids as “free centroids”. For cell types that are
unique to the target data, although there are no initial centroids allocated to them, those
“free centroids” may move and are used to cluster those unseen cell types in the target
data over iterations. Due to this reason, cell types that are unique in the source data can
provide ItClust more flexibility and help cluster cell types that are unique in the target
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data. Thus, ItClust prefers a source dataset with comprehensive cell types, and such
dataset can be obtained by combining multiple well-labeled datasets together.
2.2.5. Parameter Optimization for the Source and Target Networks
The source and target networks are optimized using the deep embedding clustering
algorithm [71]. First, we define the metric of distance from a cell to a cluster centroid.
Following van der Maaten & Hinton [72], we use the Student’s t-distribution as a kernel
to measure the distance between the embedded point 𝑧) = 𝑓$ (𝑥) ) ∈ 𝑍 for cell 𝑖 and
centroid 𝜇& for cluster 𝑗:
*

𝑞)& =

@1 + B𝑧) − 𝜇& B E𝛼F

+,
+,

*

,

∑&( @1 + B𝑧) − 𝜇&( B E𝛼 F

where 𝛼 is the degree of freedom of the Student’s t-distribution and was set at 1 in our
implementation. The distance 𝑞)& can also be interpreted as the probability of assigning
cell 𝑖 to cluster 𝑗.
Next, we iteratively refine the clusters by defining an auxiliary target distribution 𝑷
based on 𝑞)& . The choice of 𝑷 is important for ItClust’s performance. We define the
auxiliary target distribution as:

𝑝)& =

*
𝑞)&
E∑!)-, 𝑞)&
* ∑!
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E )-, 𝑞)& J

,

which upweights cells assigned with high confidence, and normalizes the contribution of
each centroid to the overall loss function to prevent large clusters from distorting the
hidden feature space. Now that we have the soft assignment 𝑞)& and the auxiliary
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distribution 𝑝)& , we can define the objective function as a Kullback-Leibler (KL)
divergence loss:
!

.

𝐿 = 𝐾𝐿(𝑃||𝑄) = P

)-,

P

&-,

𝑝)& 𝑙𝑜𝑔

𝑝)&
.
𝑞)&

The network parameters and cluster centroids are simultaneously optimized by
minimizing 𝐿 using Stochastic Gradient Descent with momentum. The gradient of 𝐿 with
respect to 𝑧) and 𝜇& are derived as:
* +,

B𝑧) − 𝜇& B
𝜕𝐿 𝛼 + 1 .
=
P U1 +
V
𝜕𝑧)
𝛼
𝛼
&-,

× I𝑝)& − 𝑞)& J I𝑧) − 𝜇& J,

* +,

B𝑧) − 𝜇& B
𝜕𝐿
𝛼+1 !
=−
P U1 +
V
𝜕𝜇&
𝛼
𝛼
)-,

× I𝑝)& − 𝑞)& J I𝑧) − 𝜇& J.

The gradients 𝜕𝐿⁄𝜕𝑧) are used in standard backpropagation to calculate the network’s
parameter gradients 𝜕𝐿⁄𝜕𝜃 and 𝜕𝐿⁄𝜕𝜇& , which are used to update the cluster centroids
after finishing each batch with size 𝑏 (for example, 𝑏 = 256) by
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The algorithm will stop if either of these two conditions is met: 1) the number of
iterations trained on the target data exceeds 2,000, the maximum number of iterations
we set; 2) The percentage of cells with different predicted cell type labels between the
current iteration and last iteration is less than 0.1%, the default tolerance level in ItClust.
2.2.6. Architecture of the Neural Network in ItClust
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The number of layers and nodes for each layer depends on the sample size in the source
data. Larger source data typically contain more information on cell types, and often
require a larger network to store such information. We suggest different numbers of
hidden layers and different numbers of nodes in the encoder. We notice that the
numbers of layers and nodes per layer had little impact on ItClust’s performance.
2.2.7. Cell Type Assignment
In addition to clustering, we also aim to leverage cell type information in the source data
to help cell type assignment in the target data. Unlike most supervised cell type
classification methods that predict cell type for each individual cell, ItClust provides a
confidence score for each cluster to assist cell type annotation for all cells in that cluster.
Since the source dataset is well-labeled, before fine-tuning, each cluster centroid in our
model represents a known cell type present in the source data. For example, assume
cluster 𝑖 is used to cluster cell type 𝑖 in the source data before fine-tuning. We first use
the pre-fine-tuned model to assign clusters for cells in the target data. Let 𝒜),49:;<9
represent the set of cells in the target data that are assigned to cluster 𝑖. Since the prefine-tuned model was solely trained on the source data, cells in 𝒜),49:;<9 have gene
expression patterns that resemble cell type 𝑖 in the source data. During iterative finetuning, as the centroid for cluster 𝑖 keeps updating its location, some cells in the target
data may be added to and other cells may be removed from cluster 𝑖. After fine-tuning is
finished, we get another set of cells 𝒜),=:/9< , which consists all target cells that are
assigned to cluster 𝑖. If the centroid for cluster 𝑖 is still used to cluster cell type 𝑖 in the
target data, a big proportion of cells in set 𝒜),49:;<9 should also be present in 𝒜),=:/9< .
Based on this idea, a confidence score for each cluster can be calculated as the
proportion of original cells in the final cluster:
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This confidence score measures how confident that cells in a given cluster in the target
data are similar to a cell type that is present in the source data.
2.2.8. Data Preprocessing and Quality Control
ItClust can handle data in different formats including UMI count, FPKM, or TPM etc. All
data follow the same preprocessing procedure. First, for both the source and target data,
a cell is filtered out if the number of genes with non-zero expression is less than 100. We
further remove MT and ERCC genes and genes that are expressed in less than 10 cells.
The gene expression values are then normalized. In the first step, cell level normalization
is performed in which each gene’s expression in each cell is divided by the total gene
expression level in the cell, multiplied by 10,000, and then transformed to a natural log
scale. In the second step, gene level normalization is performed in which the cell level
normalized values for each gene are standardized by subtracting the mean across all cells
and divided by the standard deviation across all cells for the given gene.
Highly variable genes are selected using the filter_genes_dispersion function from the
Scanpy package [73] (https://github.com/theislab/scanpy). Selection of top highly
variable genes is based on the target dataset only. By doing this, we ensure that all
selected genes are informative to distinguish cells in the target data. Next, we find the
overlap between the highly variable genes in the target data and those that are present in
the source data, and we then extract the expression patterns of these overlapped genes
from the source data.
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2.2.9. Downsampling Experiments on UMI Counts
We performed downsampling experiments only for datasets with UMI counts. To
generate a downsampled dataset from the original scRNA-seq data, we selected highquality cells and genes with high expression from the original dataset. The observed
expression level of gene 𝑔 for cell 𝑐 is treated as the true expression 𝜆>? . We generate
downsampled datasets by drawing from a Poisson distribution with mean parameter
𝜏? 𝜆>? , where 𝜏? is the cell-specific efficiency. This ensures the downsampled dataset and
the original dataset are similar in mean expression and the percentage of zero entries. To
mimic variation in efficiency across cells, we sampled 𝜏? as follows, 75% efficiency with
𝜏? ~𝐺𝑎𝑚𝑚𝑎(10, 0.075), 50% efficiency with 𝜏? ~𝐺𝑎𝑚𝑚𝑎(10, 0.0.05), 25% efficiency with
𝜏? ~𝐺𝑎𝑚𝑚𝑎(10, 0.025), and 10% efficiency with 𝜏? ~𝐺𝑎𝑚𝑚𝑎(10, 0.01).

2.3. Results
2.3.1. Overview of the Method and Evaluation
ItClust requires two input datasets, a source dataset that includes cells with wellannotated cell type labels, and a target dataset that includes cells that need to be
clustered and annotated. Fig. 2.1 shows an overview of the ItClust algorithm. ItClust
starts from building a source network to extract cell type-specific gene expression
signatures from the source data. This step enables initializing the second, which is the
target network, with parameters estimated from the source network. The initialized
target network is then further trained using cells in the target data to fine-tune the
parameters, so that cell type-specific gene expression signatures in the target data are
captured. This step is critical when there is strong batch effect between the source and
target data, or when the source data have poor quality. Once fine-tuning is finished, the
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target network then returns clustered cells in the target data. As a data-driven approach,
ItClust utilizes information from both the source and target data for clustering. This is
different from prediction based methods such as Moana [12], which only uses
information in the source data to build the prediction model.

Figure 2. 1: Overview of the ItClust framework.

To showcase the strength and scalability of ItClust, we analyzed multiple scRNA-seq
datasets from different species and tissues generated with different scRNA-seq protocols
(Table 2.1). The performance of ItClust was compared with two unsupervised clustering
methods including Louvain [7] and DESC [74], one semi-supervised method
implemented in scVI[66], and three supervised cell type classification methods including
Seurat 3.0 [68], Moana [12], and scmap [10]. We also compared ItClust with SAVER-X
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[75], an unsupervised transfer learning algorithm for gene expression denoising. Our
results show that ItClust consistently performs better than these existing methods in
clustering and cell type classification.
Table 2.1. Datasets analyzed in ItClust.

Dataset

Organis
m
Mouse

Pancreas

Number
of cells
1,886

Experiment
al protocol
InDrop

Baron et
al.[76]

Human

Pancreas

8,569

InDrop

Xin et
al.[77]
Grün et
al.[78]

Human

Pancreas

1,492

SMARTer

Human

Pancreas

1,004

CelSeq

Muraro et
al.[79]

Human

Pancreas

2,285

CelSeq2

Baron et
al.[76]

Tissue
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Cell types (number of
cells)
beta (894); ductal (275);
delta (218); alpha (191);
endothelial (139);
quiescent stellate (47);
gamma (41); macrophage
(36); activated stellate
(14); B cell (10); immune
other (8); T cell (7);
schwann (6).
beta (2,525); alpha (2,326);
ductal (1,077); acinar
(958); delta (601);
activated stellate (284);
gamma (255); endothelial
(252); quiescent stellate
(173); macrophage (55);
mast (25); epsilon (18);
schwann (13); T cell (7).
alpha (886); beta (472);
gamma (85); delta (49).
ductal (327); acinar (228);
alpha (191); beta (161);
delta (50); activated
stellate (19); gamma (18);
endothelial (5); schwann
(1); quiescent stellate (1);
mast (1); macrophage (1);
epsilon (1).
alpha (843); beta (445);
acinar (274); ductal (258);
delta (203); gamma (110);
activated stellate (90);
endothelial (21);
macrophage (15);
quiescent stellate (12);
mast (6); schwann (4);
epsilon (4).

Lawlor et
al.[80]

Human

Pancreas

638

Fluidigm C1

Segerstolpe
et al.[81]

Human

Pancreas

2,394

Smart-Seq2

Park et
al.[82]

Mouse

Kidney

43,745

10X

Our own
data

Human

Kidney

15,693

10X

Peng et
al.[83]

Macaque
s 1,2, and
3

Retina

25,597

Drop-seq

Peng et
al.[83]

Macaque
4

Retina

4,705

Drop-seq

Paul et
al.[84]

Mouse

Bone
marrow

2,730

MARS-seq
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beta (258); alpha (239);
ductal (36); delta (25);
acinar (21); gamma (18);
activated stellate (16);
endothelial (14); schwann
(5); mast (3); quiescent
stellate (1); macrophage
(1); epsilon (1).
alpha (1,008); ductal (444);
beta (308); gamma (213);
acinar (188); delta (127);
activated stellate (55);
endothelial (21); epsilon
(8); Mast (7); macrophage
(7); quiescent stellate (6);
schwann (2).
PT (26,482); DTC (8,544);
CD-IC (1,729); LOH (1,581);
T lymph (1,308); Endo
(1,001); CD-PC (870); Novel
(643); Fib (549); NK (313);
B lymph (235); Macro
(228); CD-Trans (110);
Podo (78); Neutro (74).
PT (3,695); Macrophage
(3,566); T Cells (2,721);
Endo (1,837); NK_Cells
(1,430); CD_IC (1,297);
Loop of Henle (551); Distal
Tubules (383); B Cells
(213).
IMB (5,066); FMB (4,457);
RB (2,814); DB5* (2,775);
DB3b (2,538); DB4 (2,340);
DB2 (1953); BB/GB*
(1488); DB1 (935); DB3a
(605); DB6 (547); OFFx
(79).
RB (1262); IMB (1085);
DB5* (692); DB4 (645);
BB/GB* (327); DB2 (291);
DB6 (111); DB3b (102);
OFFx (68); DB1 (61); FMB
(43); DB3a (18).
1Erythrocyte (43);
2Erythrocyte (329);
3Erythrocyte (246);

Tusi et
al.[85]

Mouse

Bone
marrow

4,763

InDrop

4Erythrocyte (124);
5Erythrocyte (180);
6Erythrocyte (173);
7Megakaryocyte/Erythroc
yte_progenitors (167);
8Megakaryocyte (68);
9Granulocyte/Macrophag
e_progenitors
(63);10Granulocyte/Macr
ophage_progenitors
(153); 11Dendritic (30);
12Basophils (69);
13Basophils (300);
14Monocyte (373);
15Monocyte (186);
16Neutrophils (164);
17Neutrophils (22);
18Eosinophils (9);
19Lymphocyte (31).
Erythroid (1922);
Granulocytic neutrophil
(1570); Monocyte (468);
Lymphoid (238); Dendritic
(207); Megakaryocyte
(180); Basophil/Mast (178).

2.3.2. Comparison with Unsupervised Clustering Methods
To show that incorporating cell type-specific gene expression information from welllabeled source data helps clustering in target data, we compared ItClust with Louvain
and DESC, two unsupervised clustering algorithms. Louvain is a graph-based clustering
method that has shown popularity in scRNA-seq analysis. DESC is an unsupervised
neural network-based clustering method that is effective in removing batch effect while
maintaining high clustering accuracy. Since both are unsupervised, these two methods
cannot utilize prior cell type information from a well-labeled source dataset. To make a
fair comparison, we also compared ItClust with SAVER-X, a neural network-based
method originally designed for denoising of gene expression in scRNA-seq data. SAVER25

X starts from extracting gene expression signatures from a source dataset and then
denoises the unique molecular identifier (UMI) counts in target data with the learned
prior knowledge on gene expression. After the data are denoised, clustering analysis can
then be performed using algorithms such as Louvain. SAVER-X does not specifically
utilize cell type label information in the source data.
We analyzed four publicly available datasets on human pancreatic islets generated using
Fluidigm C1 (Lawlor data [86]), SMART-seq2 (Segerstolpe data [87]), CEL-seq (Grün
data[88]), and CEL-seq2 (Muraro data [89]), respectively, as the target data. The human
pancreatic islet data from Baron et al. [90], generated using InDrop, was used as the
source data since this dataset contains a large number of cells from 14 well-annotated
cell types. For SAVER-X, the denoising performed using their pretrained model that
includes both mouse and human pancreatic islet data. We first analyzed the four target
datasets individually, and then combined them together to form a dataset to test whether
ItClust is robust in the presence of batch effect in the target data. Cell type labels from
the original publications were treated as the ground truth. Although the source and
target data are both from the same species and the same tissue, they were generated
through different scRNA-seq protocols, which result in strong batch effect between the
source and target data and make transferring of cell type-specific gene expression
knowledge difficult.
Since the performance of both the Louvain and DESC algorithms depends on
‘resolution’, a hyper-parameter that controls the number of clusters and needs to be
specified by users, we tried a range of values from 0.2 to 2 with a step of 0.2. The
Adjusted Rand Index (ARI) was used as the evaluation metric for clustering accuracy.
Fig. 2.2a shows that across all four individual target datasets, the ARIs for Louvain,
DESC, and SAVER-X vary substantially as the resolution parameter varies. By contrast,
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ItClust does not require the specification of the resolution parameter, and always had the
highest or near the highest ARI even when comparing with the best performing
resolution used by Louvain, DESC, or SAVER-X. For the combined dataset, the ARIs for
Louvain, DESC, and SAVER-X dropped substantially because they tend to cluster cells
from the same cell type but different datasets into different clusters, whereas ItClust
maintained high clustering accuracy and is robust in the presence of batch effect in the
target data (Fig. 2.2b). We note that unsupervised clustering algorithms such as DESC
relies on batch indicator for standardization within each batch to remove batch effect,
but supervised method such as ItClust does not need batch information in the target
data.
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Figure 2. 2: Comparison of ItClust with unsupervised methods on human pancreatic islet datasets.
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For Louvain, DESC, and SAVER-X, they can only separate major cell types even with
increased resolution. As the resolution increases, Louvain and DESC tend to split major
cell types into multiple sub clusters. To select an optimal resolution for each method, we
first performed principal component analysis on the preprocessed gene expression data
for the target dataset and used the top 50 principal components as the embedded
features. Next, we picked the resolution that gave the highest silhouette coefficient
calculated using the embedded features across the range of resolutions that were
evaluated. However, even with the optimal resolution, the minor cell types still mixed
with other cells for Louvain, DESC, and SAVER-X. By contrast, ItClust clearly revealed
separate clusters for those minor cell types (Fig. 2.2 c). The superior performance of
ItClust over other methods is due to its use of cell type label information in the source
data. Through training in the source data with well labeled cells, ItClust extracted gene
expression signatures for each cell type, thus avoiding capturing information on batch
effect, which makes it more sensitive to detect rare cells. Although SAVER-X also utilized
prior information from the source data for denoising, cell type label information in the
source data was not utilized, thus it did not show significant improvement in ARI after
denoising compared to Louvain, which used the original gene expression data as the
input.
2.3.3. Comparison with Semi-supervised and Supervised Cell Type Classification
Methods
Next, we compared ItClust with semi-supervised and supervised cell type classification
methods. In addition to clustering, ItClust also provides a confidence score for each
cluster, which indicates the degree of similarity of a cluster in the target data to an
annotated cell type in the source data. Clusters with high confidence scores can be
assigned with cell type names based on the corresponding annotations in the source
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data. For clusters with low confidence scores, they might represent cell types that are not
present in the source data. In this case, we annotate their cell type names by known
marker genes, which can be obtained from databases such as PanglaoDB [91] or
CellMarker [92].
To evaluate ItClust’s performance for cell type classification, we assigned cell type names
using approach described above, and compared ItClust with other semi-supervised or
supervised cell type classification methods based on accuracy, which is defined as the
proportion of cells with correctly labeled cell type names. For semi-supervised methods,
we selected scVI [66] due to its popularity. Among the pool of supervised classification
methods, we selected Seurat 3.0 [68], Moana [12], and scmap [10] as our competitors.
Seurat 3.0 is the most popular scRNA-seq analysis pipeline, and its cell type
classification has shown good performance in recent publications. In Abdelaal et al. [93],
SVM based methods are shown to have the best performance for intra-dataset
classification. We chose Moana as a representative of the SVM family methods. Scmap is
shown to be one of the best methods with a rejection option, which allows assigning cell
types that are not present in the source data but are present in the target data as
“unassigned”.
2.3.3.1. Within-species Transfer
First, we considered the situation when source and target data are from the same species.
We used the same four human pancreatic islet datasets analyzed previously as the target
data, and the Baron human data as the source data. When considering each of the four
target datasets separately, ItClust achieved the best performance in general, yielding the
highest or near the highest classification accuracy (Fig. 2.3a). The next best performing
method is scmap, followed by Seurat 3.0, scVI, and Moana. Although scVI performed
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well for some datasets, its performance is substantially worse than the other methods for
the Lawlor et al. dataset. Closer examination indicates that such poor performance is due
to its failure in removing batch effect.

Figure 2. 3: Comparison of ItClust with semi-supervised and supervised methods on human pancreatic islet
datasets when source and target data are from the same species.

When the four target datasets were combined as a single target dataset, ItClust still
achieved a high accuracy of 0.95 with each cluster corresponding to one cell type (Fig.
2.3b), which indicates its robustness to batch effect in the target data. Although Seurat
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3.0 also achieved a high accuracy of 0.89, it tends to assign acinar cells to ductal cells
(Fig. 2.3b). Seurat 3.0 uses an unsupervised strategy to pair anchor cells between two
datasets, and cell type assignment in the target data is based on these anchors. By
examining the overlap of mutual nearest neighbors for two cells in a pair, Seurat 3.0 also
gives an anchor quality score that measures the similarity between the two cells. To
further investigate why ItClust performed better than Seurat 3.0, we examined the
anchors identified by Seurat 3.0. Among the 628 anchors for ductal cells in the source
data, 189 anchors were mis-paired with an acinar cell in the target data, but these mispaired anchors still have average anchor quality score of 0.85, which is significantly
higher than the average anchor quality score for all 1,400 anchors (0.62). The mismatch
of anchor cells is possibly due to the close relatedness of acinar and ductal cells in
cellular differentiation because acinar, endocrine and ductal cells of the pancreas are all
derived from a specific region of endoderm [94]. Since the anchor searching process is
unsupervised, Seurat 3.0 would give a cell pair a high anchor score as long as they share
similar gene expression pattern, although many of the genes that drive the similarity
between the two cells are not marker genes for the corresponding cell type(s). ItClust
avoids this issue by directly utilizing cell type information in the well-labeled source data
to obtain the initial cluster centroids for the target data.
2.3.3.2. Cross-species Transfer
Next, we considered a more challenging situation with the goal of transferring cell type
knowledge learned from one species to a target dataset generated in a different species.
First, we designed an experiment to transfer information from mouse kidney to human
kidney. We used the Park et al. mouse kidney data [95] as the source data, and the
human kidney data generated ourselves combined with another human kidney dataset
generated by Young et al. [96] as the target data. Cells in the human data were clustered
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using DESC and annotated based on known marker genes [96]. As shown in Fig. 2.4a,
ItClust achieved the highest cell type classification accuracy (0.87), which is much higher
than the second best performing method Seurat 3.0 (0.69). Moana, scmap, and scVI
failed the task, yielding low accuracies of 0.20, 0.19, and 0.34, respectively. Of note,
Seurat 3.0 misclassified more than half of the macrophages (2,408 out of 3,566; 67.5%)
as fibroblasts, whereas ItClust labeled 94.6% of the macrophages correctly (Fig. 2.4b). To
further verify these results, we selected marker genes for macrophage and fibroblast, and
generated gene expression dot plots for the true cell types, and cell types predicted by
ItClust and Seurat 3.0, respectively (Fig. 2.4c). For the ItClust predicted macrophage
cluster, known macrophage marker genes are expressed, whereas those marker genes for
fibroblasts have low or no expression. By contrast, known macrophage marker genes
have high expression in fibroblasts predicted by Seurat 3.0.
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Figure 2. 4: Comparison of ItClust with semi-supervised and supervised methods on mouse and human
kidney datasets when source and target data are from different species.
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Encouraged by the above results, we further did a cross-species transfer analysis in
pancreas. We used the Xin et al. [97] data generated from human pancreatic islets as the
target data and the Baron mouse pancreatic islet data [90] as the source data. The target
dataset only contains four cell types, which are all included in the source data. Despite
the simplicity of the target data, the cross-species transfer makes it difficult as there is a
risk of transferring noise of gene expression signatures that are only present in mouse
but absent in human. As shown in Fig. 2.4d, ItClust still achieved the highest
classification accuracy (0.89), much higher than the second-best performing method
scVI (0.27). This is further confirmed by the Sankey plots shown in Fig. 2.4e. The
significant advantage of ItClust over other methods is due to the iterative fine-tuning
step, which enables the extraction of useful information that distinguishes cell types in
the target data. The fine-tuning step is a critical advantage that differentiates ItClust
from other supervised cell type classification methods.
2.3.3.3. Cell Types that are not Present in the Source Data
In many studies, the target data may contain cell types that are not present in the source
data. To this end, we tested how unique cell types in the target data affect the
performance of different methods. We made a human pancreas benchmark dataset
based on the Baron human [90] and the Segerstolpe human data [87]. As shown
previously, ItClust achieved the highest classification accuracy (0.97) in the Segerstolpe
data with the Baron human data serving as the source. This provides an appropriate
benchmark scenario that allows us to investigate how cell type classification accuracy
varies as certain cell types are eliminated from the source data.
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First, we considered a situation in which rare cell types are present in the target data but
are missing in the source data. To do so, cells from epsilon, mast, macrophage, quiescent
stellate, and schwann were eliminated from the Baron human data. As shown in Fig.
2.5a, ItClust still achieved a high accuracy of 0.96. The other methods also showed
relatively high accuracies, with 0.92 for Seurat 3.0, 0.89 for Moana, 0.94 for scmap, and
0.81 for scVI. These results indicate that missing rare cells types in the source data had
little impact for all evaluated methods except for scVI.
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Figure 2. 5: Comparison of ItClust with semi-supervised and supervised methods on human pancreatic islet
datasets to evaluate the impact of missing cell types in source data.
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Next, we considered a more challenging situation by excluding four main cell types,
including alpha, beta, gamma, and delta cells, from the source data. Fig. 2.5b shows that
ItClust still achieved a high accuracy of 0.86 and was able to separate these four cell
types correctly, although they were absent in the source data. By contrast, the accuracy of
Seurat 3.0 dropped substantially to 0.25, since it assigned most of the four missing cell
types as ductal (Fig. 2.5c). Scmap’s accuracy dropped to 0.28, and an additional 55.0% of
the cells, including most of the alpha, beta, and gamma cells along with some acinar and
delta cells, were classified as “unassigned,” and most of the delta cells (99 out of 127,
78.0%) were mis-assigned as epsilon cells. scVI’s accuracy dropped to 0.25, also
classified most of the unseen cells as epsilon cells. Moana had the lowest accuracy of 0.21
with most of the unseen cells misclassified as epsilon cells.
The reason that ItClust can separate these unseen cell types is that during the fine-tuning
step, our model captured information of these unique cell types in the target data by
updating the network parameters. Through iterative fine-tuning, these four cell types
were gradually separated from the other cell types based on cell type-specific gene
expression information gained from the target data. To better illustrate how the finetuning process works, we use gamma cells as an example. Fig. 2.5d shows a t-SNE plot of
cells in the target data before fine-tuning. The blue dots represent those true gamma
cells, and the red dot is the cluster centroid and the beige dots represent cells from the
other cell types. Although we transferred cell type information from the source data to
the model, because the gamma cells were absent in the source data, the initialized
network was unable to separate those unseen gamma cells. Thus, in the t-SNE plot,
gamma cells mixed together with the other unseen cell types initially. However, during
the fine-tuning step, our model started to capture information of these unique cell types
in the target data. Through iterations, the gamma cells were moving closer to the red
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centroid, which pulled the gamma cells away from cells that originate from cell types.
After 70 iterations, the gamma cells were completely separated from the other cells.
Similar patterns were also observed for alpha, beta and delta cells. These results indicate
that for unseen cell types, if there is enough information in the target data, ItClust is able
to utilize such information and cluster cells from those unseen cell types well.
2.3.3.4. Combined Source Data
In situations when it is hard to find one dataset that contains all needed cell types as the
source, a simple solution is to combine multiple datasets to form a complementary
dataset that includes as many cell types as possible, and then use this combined dataset
as the source data. In this section, we demonstrate that ItClust is robust to batch effect in
the combined source data and is able to extract useful information to help improve
clustering and cell type classification. As shown in the previous section, when excluding
the four main cell types (alpha, beta, gamma, and delta) from the Baron human source
data, ItClust still had good classification accuracy on the Segerstolpe dataset. Here, we
combined the reduced Baron human data with the Xin data, which only contain the four
missing cell types, to generate a new combined source dataset. With this combined
dataset as the source data, the overall classification accuracy of ItClust increased from
0.92 to 0.96. The Sankey plot also shows that alpha, beta, gamma, and delta cells were
all classified better. The classification accuracies for scVI, Seurat 3.0, scmap, and Moana
also improved when using the combined source data as the training data, but their
accuracies are still lower than ItClust.
2.3.3.5. Read Depth Down Sampling Experiments
Many scRNA-seq studies suffer from low sequencing depth although they can easily
generate a large number of cells. To evaluate the performance of ItClust when the source
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data have low sequencing depth, we performed read depth down sampling experiments
using a scRNA-seq dataset on retina bipolar cells from four macaques [98]. We merged
cells from the first three macaques and used the merged data as the source data, and
cells from the fourth macaque as the target data. Since the source and target data are
from the same study and were generated using the same protocol, ItClust, Seurat 3.0,
scmap, and Moana all achieved high classification accuracy, thus providing an
appropriate testing case for down sampling evaluation.
To do read depth down sampling on the source data, we set the sampling efficiency at
75%, 50%, 25%, and 10%, respectively [64], with lower efficiency corresponding to lower
sequencing depth. We fund that as efficiency decreases, the accuracy of all methods
declined. For example, when the sampling efficiency is 10%, the accuracy of scVI
dropped from 0.97 to 0.86, and the accuracies of both Seurat 3.0 and scmap dropped
substantially, 0.98 to 0.63 for Seurat 3.0, and 0.72 to 0.19 for scmap. By contrast, the
accuracy of ItClust only dropped slightly from 0.98 to 0.93. Moana failed to predict any
cells when the efficiency dropped to 25% or lower because the quality of the source data
is too low and Moana failed to build a prediction model. Compared to Seurat 3.0, ItClust
is more robust to decline in read depth and less sensitive to the quality of the source
data. This is because the anchor pairs identified by Seurat 3.0 depend on the quality of
both the source and target data. When the source data quality is low, Seurat 3.0 has
difficulty finding trustworthy anchor pairs. Since ItClust extracts cell type-specific gene
expression in the target data through fine-tuning, it still gave high classification accuracy
by utilizing more information in the target data. We found that the fine-tuning step in
ItClust significantly improved the classification accuracy when efficiency is as low as 25%
and 10%. The ability to extract cell type-specific gene expression signatures from both
the source and target data makes ItClust flexible.
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2.3.3.6. Cell Type Assignment
In this section, we leverage cell type information in the source data to help cell type
assignment in the target data. We define a confidence score that measures how confident
that cells in a given cluster in the target data are similar to a cell type that is present in
the source data (Fig. 2.6a). For example, most of the red cells in the target data are
initially assigned to centroid 2 that corresponds to cell type 2 in the source data, but
switched to centroid 3 corresponding to cell type 3 in the source data after fine-tuning, as
the location of these two centroids are changed over iterations. By contrast, the blue cells
in the target data are consistently assigned to centroid 1 corresponding to cell type 1 in
the source data before and after fine-tuning. Therefore, the blue cells in cluster 1 have a
high confidence score to be assigned as cell type 1 and the red cells in cluster 3 have a low
confidence score to be assigned as cell type 3.
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Figure 2. 6: Confidence scores in ItClust.
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To evaluate the effectiveness of the confidence score, first, we consider the human
pancreas data in the within species transfer section in which the source and target data
include the same cell types. As shown in Fig. 2.6b, all clusters have high confidence
scores, indicating high similarity between the source and target data. As another
example, we calculated the confidence scores for the human pancreas data in which the
four major cells were excluded from the source data. Fig. 2.6c shows that clusters 1 and 2
have relatively high confidence scores of 0.96 and 0.94, respectively. These two clusters
correspond to activated stellate cells and ductal cells in the original source data.
Therefore, we can confidently assign them as activated stellate cells and ductal cells for
cells in the target data. For the other clusters with low confidence scores, we would
encourage users to look at expression levels for known marker genes or use algorithms
such as ACTIONet [99] for automatic cell type annotation.

2.4. Discussion
Clustering and cell type classification are important steps in scRNA-seq analysis. In this
chapter, we presented ItClust, a supervised clustering algorithm that employs a transfer
learning framework. ItClust has been extensively tested using datasets from different
species (mouse, macaque, and human), different tissues (pancreas, kidney, and retina)
generated using nine different scRNA-seq protocols (10X, inDrop, DropSeq, SeqWell,
CelSeq, CelSeq2, SmartSeq2, Fluidigm C1, and Smarter). Comparison of ItClust with
other unsupervised clustering methods showcased that it always achieves high ARIs
without the need of tuning any hyper-parameters such as resolution. The comparison
with popular supervised cell type classification methods, i.e., Seurat 3.0, scVI, Moana,
and scmap, also supported ItClust’s consistent high performance in all evaluated
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scenarios. Additionally, ItClust is robust to network architecture, mislabeling of cell
types in source data, and can preserve continuous structure for cells generated from a
continuous transcriptional phenotype.
The success of ItClust comes from its unique way of information extraction and
integration. Different from other methods, ItClust first extracts information from the
source data by considering genes that are highly variable in the target data. This step
ensures that all the transferred expression patterns are useful for separating cell types in
the target data. These expression patterns are further updated based on information in
the target data through iterative fine-tuning. Compared to existing supervised
classification methods, the extraction of cell type knowledge in ItClust is tailored more
towards the target data, which makes it more effective than other methods.
In summary, ItClust has shown to be a powerful tool for scRNA-seq clustering and cell
type classification. It can accurately extract information from source data and apply it to
help cluster cells in target data. It is robust to strong batch effect between source and
target data, and is able to separate unseen cell types in the target. Furthermore, it
provides confidence scores that facilitate cell type assignment. With the increasing
popularity of scRNA-seq in biomedical research, we expect ItClust will make better
utilization of the vast amount of existing well-annotated scRNA-seq datasets, and enable
researchers to accurately cluster and annotate cells in their studies.
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Chapter 3: SpaGCN: Integrating gene expression, spatial location and
histology to identify spatial domains and spatially variable genes by graph
convolutional network

3.1. Introduction
Recent technological advances in spatially resolved transcriptomics (SRT) have enabled
gene expression profiling with spatial information in tissues [100]. Knowledge of the
relative locations of different cells in a tissue is critical for understanding disease
pathology because spatial information helps in understanding how the gene expression
of a cell is influenced by its surrounding environment. Popular experimental methods for
SRT can be broadly classified into two categories. The first category is in situ
hybridization- or sequencing-based technologies with single-cell resolution, which
includes seqFISH [29, 101], seqFISH+ [30], MERFISH [31, 102], STARmap [103], and
FISSEQ [104] that measure the expression level for hundreds to thousands of genes in
cells within their tissue context. The second category is in situ capturing-based
technologies with spatial barcoding followed by sequencing, which include Spatial
Transcriptomics (ST) [32], SLIDE-seq [33], SLIDE-seqV2 [105], HDST [35], and 10x
Visium that measure the expression level for thousands of genes in captured locations,
referred to as spots. These different SRT technologies have made it possible to uncover
the complex transcriptional architecture of heterogenous tissues and enhanced our
understanding of cellular mechanisms in diseases [38, 42].
In SRT studies, an important step is identifying spatial domains defined as regions that
are spatially coherent in both gene expression and histology. Traditional clustering
methods such as K-means and Louvain’s method [7] only take gene expression data as
input, and the resulting clusters may not be contiguous due to the lack of consideration
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of spatial information and histology. To account for spatial dependency of gene
expression, new methods have been developed. For example, Zhu et al. [106] uses a
Hidden-Markov random field (HMRF) approach to model spatial dependency of gene
expression; stLearn [45] uses features extracted from histology image as well as
expression of neighboring spots to spatially normalize gene expression data before
clustering; BayesSpace [46] employs a Bayesian approach for clustering by imposing a
prior that gives higher weight to spots that are physically close. Although these methods
can cluster spots or cells into distinct groups, the lack of flexibility with different
modalities has made them less versatile. As newer SRT technologies are continued to be
developed [107-110], it is desirable to have methods that are compatible with different
SRT platforms.
To link spatial domains with biological functions, it is crucial to identify genes that show
enriched expression in the identified domains. Methods such as Trendsceek [48],
SpatialDE [49], and SPARK [50] have been developed to detect spatially variable genes
(SVGs). These methods examine each gene independently and return a p-value to
represent the spatial variability of a gene. However, due to the lack of consideration of
spatial domains, genes detected by these methods do not have guaranteed spatial
expression patterns, making it difficult to utilize these genes for further biological
investigations.
Rather than considering spatial domain and SVG identification as separate problems, we
developed SpaGCN, a graph convolutional network (GCN)-based approach that
considers these two problems jointly. SpaGCN first identifies spatial domains by
integrating gene expression, spatial location, and histology together through the
construction of an undirected weighted graph that represents the spatial dependency of
the data. For each spatial domain, SpaGCN then detects SVGs that are enriched in the
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domain. By restricting the search space to spatial domains, the SVGs detected by
SpaGCN are guaranteed to have spatial expression patterns. The spatial domains and the
corresponding SVGs provide a comprehensive picture on the spatial gradients in gene
expression in tissue. SpaGCN is versatile in analyzing many types of SRT data, including
ST, 10x Visium, SLIDE-seqV2, STARmap, and MERFISH.

3.2. Materials and Methods
3.2.1. Data Preprocessing
SpaGCN takes spatial gene expression and histology image data (when available) as
input. For ease of explanation, we will use in situ capturing-based spatially resolved
transcriptomics (SRT) data to illustrate the method. The spatial gene expression data are
stored in an 𝑁 × 𝐷 matrix of unique molecular identifier (UMI) counts with 𝑁 spots and
𝐷 genes, along with the (𝑥, 𝑦) 2-dimensional spatial coordinates of each spot. Genes
expressed in less than three spots are eliminated. The gene expression values in each
spot are normalized such that the UMI count for each gene is divided by the total UMI
count across all genes in a given spot, multiplied by 10,000, and then transformed to a
natural log scale.
3.2.2 Conversion of SRT Data into Graph-structured Data
After preprocessing, SpaGCN converts the gene expression and histology image data into
a weighted undirected graph, 𝐺(𝑉, 𝐸). In this graph, each vertex 𝑣 ∈ 𝑉 represents a spot
and every two vertices in 𝑉 are connected via an edge with a specified weight. We note
that spage2vec [111] also employed a graph-based approach, but with the goal of
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clustering mRNA molecules in which each node represents an mRNA. Such
segmentation-free approach may offer advantages over methods that require segmented
cells as cell segmentation is still one of the hardest problems in single-cell analysis.
3.2.2.1. Calculation of Distance between Two Vertices
The distance between any two vertices 𝑢 and 𝑣 in the graph reflects the relative similarity
of the two corresponding spots. This distance is determined by two factors: 1) the
physical locations of spots 𝑢 and 𝑣 in the tissue slice, and 2) the corresponding histology
information of these two spots. Although some spots are physically close to each other in
the tissue, the histology image may reveal them belonging to different tissue layers.
Therefore, SpaGCN considers two spots to be close if and only if 1) the two spots are
physically close, and 2) they have similar histological features as shown in the histology
image. To define a distance metric considering both aspects, SpaGCN extends the 2dimensional space in the tissue slice into a 3-dimensional space that incorporates
histology information. For spot 𝑣, its physical location in the tissue slice is represented
by 2-dimensional coordinates (𝑥@ , 𝑦@ ). To determine the corresponding pixel in the
histology image for spot 𝑣, SpaGCN maps spot 𝑣 to the histology image according to its
pixel coordinates (𝑥#@ , 𝑦#@ ). Instead of using the color of the pixel at (𝑥#@ , 𝑦#@ ), SpaGCN
draws a square centered on (𝑥#@ , 𝑦#@ ) containing 50 × 50 pixels and calculates the mean
color value for the RGB channels, (𝑟@ , 𝑔@ , 𝑏@ ), of all pixels that fall in the square. This step
smooths the color value and ensures that the color is not dominated by a single pixel. To
derive a single value to represent the histology image features, SpaGCN uses a weighted
sum of the RGB values as follows,

𝑧@ =

𝑟@ × 𝑉< + 𝑔@ × 𝑉> + 𝑏@ × 𝑉4
,
𝑉< + 𝑉> + 𝑉4
48

Where 𝑉< = Variance(𝑟@ ), 𝑉> = Variance(𝑔@ ), and 𝑉4 = Variance(𝑏@ ) for all 𝑣 ∈ 𝑉. In this
transformation, higher weight is given to the channel with larger variance so that this
combined value 𝑧@ captures an accurate representation of the patterns in the histology
image.
Next, SpaGCN rescales 𝑧@ as
𝑧@∗ =

𝑧@ − 𝜇6
× maxI𝜎B , 𝜎C J × 𝑠,
𝜎6

where 𝜇6 is the mean of 𝑧@ , 𝜎B , 𝜎C , 𝜎6 are the standard deviations of 𝑥D , 𝑦D
and 𝑧D , respectively, for 𝜈 ∈ 𝑉, and 𝑠 is a scaling factor. By default, 𝑠 is set at 1 to ensure
that 𝑧@∗ has the same scale variance as 𝑥@ and 𝑦@ , and we set 𝑠 to a value larger than 1
when the goal is to increase the weight of histology. The coordinates of spot 𝑣 are set to
be (𝑥@ , 𝑦@ , 𝑧@∗ ) in the extended 3-dimensional space. Finally, the Euclidean distance
between every two spots 𝑢 and 𝑣 is calculated as
𝑑(𝑢, 𝑣) = }(𝑥E − 𝑥@ )* + (𝑦E − 𝑦@ )* +(𝑧E∗ − 𝑧@∗ )* .
When histology information is not available, the Euclidean distance between every two
spots will be calculated based on spatial location information only.
3.2.2.2 Calculation of weight for each edge and construction of graph
The weight of each edge (𝑢, 𝑣) measures the degree of relatedness between spots 𝑢 and 𝑣
and is negatively associated with their distance. The graph structure 𝐺 is stored in an
𝑁 × 𝑁 adjacency matrix 𝑨 = [𝑤(𝑢, 𝑣)], where the edge weight between spot 𝑢 and spot 𝑣
is defined as
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𝑤(𝑢, 𝑣) = exp Z−

𝑑(𝑢, 𝑣)*
[.
2𝑙 *

The hyperparameter 𝑙, also known as the characteristic length scale, determines how
rapidly the weight decays as a function of distance. A similar function has been employed
in SpatialDE [49]. Let 𝑰 denote the identity matrix. For spot 𝑣, the corresponding row
sum of 𝑨 − 𝑰, denoted by 𝑎@ , can be interpreted as the relative contribution of other spots
to its gene expression. By default, we choose the value of 𝑙 such that the average of 𝑎@
across all spots is equal to a pre-specified value, e.g., 0.5. For data generated from SRT
platforms with small tissue capture areas, e.g., SLIDE-seqV2, STARmap, and MERFISH,
we suggest choosing the value of 𝑙 such that neighboring spots/cells contribute more
information in gene expression aggregation.
3.2.3 Graph Convolutional Layer
SpaGCN reduces the dimension of the preprocessed gene expression matrix using
principal component analysis (PCA). The top 50 principal components are used as input,
which work well for all datasets analyzed in this chapter. Next, utilizing the power of a
graph convolutional network, SpaGCN concatenates the gene expression information
and edge weights in 𝐺 to cluster the nodes. Following Kipf and Welling[112], the graph
convolutional layer can be written as
𝑓(𝑿, 𝑨) = 𝛿(𝑨𝑿𝑩),
where 𝑿 is the 𝑁 × 50 embedding matrix obtained from PCA, 𝑩 is a 50 × 50 matrix
representing filter parameters of the convolutional layer, and 𝛿(∙) is a non-linear
activation function such as ReLU. The graph convolutional layer ensures that a
corresponding row of parameters in 𝑩 will control the aggregation of neighborhood
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information for each feature in 𝑿, thus offering the flexibility of feature specific
aggregation of information provided by neighboring spots. The filter parameters in 𝑩 are
shared across all vertices in the graph and are automatically updated during an iterative
training progress. Through graph convolution, SpaGCN has aggregated the gene
expression information according to the edge weights specified in 𝐺. The output of this
layer is an aggregated matrix that includes information on gene expression, spatial
location, and histology. The graph convolutional layer was implemented based on Kipf
and Welling [112], where the backpropagation is operated via a localized first-order
approximation of spectral graph convolution.
3.2.4. Spatial Domain Identification by Clustering
Next, based on the output from the above graph convolutional layer, SpaGCN employs
an unsupervised clustering algorithm to iteratively cluster the spots into different spatial
domains [113]. Each cluster identified from this analysis is considered to be a spatial
domain, which contains spots that are coherent in gene expression and histology. To
initialize cluster centroids, we use Louvain’s method [7] on the aggregated output matrix
from the graph convolutional layer. If the number of domains in the tissue is known, the
resolution parameter in Louvain will be set to generate the same number of spatial
domains. Otherwise, we vary the resolution parameter from 0.2 to 1.0 and select the
resolution that gives the highest Silhouette score [114].
To update the cluster assignments iteratively, we define a metric to measure the distance
from a spot to a cluster centroid using the Student’s 𝑡-distribution as a kernel. The
distance between the embedded point ℎ) for spot 𝑖 and centroid 𝜇& for cluster 𝑗
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can be interpreted as the probability of assigning cell 𝑖 to cluster 𝑗.
Next, we iteratively refine the clusters by defining an auxiliary target distribution 𝑃
based on 𝑞)&
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which upweights spots assigned with high confidence, and normalizes the contribution
of each centroid to the overall loss function to prevent large clusters from distorting the
hidden feature space. Now that we have the soft assignment 𝑞)& and the auxiliary
distribution 𝑝)& , we can define the objective function as a Kullback-Leibler (KL)
divergence loss,
G

𝐿 = 𝐾𝐿(𝑃||𝑄) = P
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The network parameters and cluster centroids are simultaneously optimized by
minimizing 𝐿 using stochastic gradient descent with momentum. This unsupervised
iterative clustering algorithm has been previously utilized for scRNA-seq analysis and
showed superior performance over Louvain’s method [115, 116].
After clustering, SpaGCN also provides an optional refinement step for the clustering
result. In this step, SpaGCN examines the domain assignment of each spot and its
surrounding spots. For a given spot, if more than half of its surrounding spots are
assigned to a different domain, this spot will be relabeled to the same domain as the
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major label of its surrounding spots. Since this refinement step only relabels a few spots,
it has little impact on the downstream SVG detection. We performed cluster refinement
only for the human dorsolateral prefrontal cortex 10x Visium data and the STARmap
data when comparing to their manual annotations with clear domain boundaries.
3.2.5 Detection of Spatially Variable Genes
We are interested in detecting spatially variable genes (SVGs) that are enriched in each
spatial domain. We note that some genes may be expressed in multiple but disconnected
domains. Although they are not uniquely expressed in a particular domain, these genes
are still useful for understanding spatial variation of gene expression and can be used to
form meta genes that are uniquely expressed in a specific domain. Therefore, rather than
doing differential expression (DE) analysis using spots from a target domain versus all
other spots, we first select spots to form a neighboring set of the target domain. The goal
is to detect genes that are highly expressed in the target domain but are not expressed or
are expressed at low levels in the neighboring spots. Fig. 3.1 illustrates how a
neighboring domain is identified. Briefly, we draw a circle with a prespecified radius
around each spot in the target domain, and spots from non-target domains but reside in
the circle are considered its neighbors. The radius is set such that each spot in the target
domain has approximately 10 neighbors on average. Next, neighbors of all spots in the
target domain are collected and form a neighboring set. For each non-target domain, if
more than 50% (default) of its spots are in the neighboring set, this domain is then
selected as a neighboring domain. This criterion is set to avoid the situation where a
domain is selected as a neighboring domain, but only a small proportion of its spots are
adjacent to the target domain.
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Figure 3. 1: Illustration of the neighboring domain detection step in SpaGCN using domain 10 (target
domain) in the human dorsolateral prefrontal cortex 10x Visium data as an example.

After neighboring domains are determined, SpaGCN then performs DE analysis between
spots in the target domain and the neighboring domain(s) using Wilcoxon rank-sum test.
Genes with a false discovery rate (FDR) adjusted p-value <0.05 are selected as SVGs. To
ensure only genes with enriched expression patterns in the target domain are selected,
we further require a gene to meet the following three criteria: 1) the percentage of spots
expressing the gene in the target domain, i.e., in-fraction, is >80%; 2) for each
neighboring domain, the ratio of the percentages of spots expressing the gene in the
target domain and the neighboring domain(s), i.e., in/out fraction ratio, is >1; and 3) the
expression fold change between the target and neighboring domain(s) is >1.5. If a user is
interested in finding SVGs for a particular combination of spatial domains, SpaGCN
offers the option to do so.
3.2.6. Detection of Spatially Variable Meta Genes
The spatial domain-specific DE analysis described above typically detects SVGs with
enriched expression for the majority of the domains. For domains in which no such SVGs
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are detected, we aim to identify a set of genes that, when combined to form a meta gene,
shows an enriched expression pattern in the given domain. To identify genes to form a
meta gene, we employ a multi-step approach. First, we lower the thresholds for SVG
filtering, e.g., change the minimum fold change threshold from 1.5 to 1.2, to identify
genes showing weaker enriched expression pattern in the target domain. In the presence
of multiple such weaker SVGs, we randomly select one of them as the base gene and
denote it as 𝑔𝑒𝑛𝑒H . Second, we aim to aggregate expression from other genes to the base
gene to enhance the spatial pattern for the target domain. To achieve this goal, we first
calculate the mean expression level of 𝑔𝑒𝑛𝑒H for spots in the target domain as 𝑒H . Then,
all spots from non-target domains with 𝑔𝑒𝑛𝑒H ’s expression level higher than 𝑒H are
extracted to form a control group. Next, we perform DE analysis using spots from the
target domain against spots in the control group using Wilcoxon rank-sum test. The gene
with the smallest FDR-adjusted p-value and higher expression in the target domain is
selected as 𝑔𝑒𝑛𝑒H0 . Similarly, we perform DE analysis using spots from the control group
against those from the target domain and select a gene with the smallest FDR-adjusted
p-value and higher expression in the control group as 𝑔𝑒𝑛𝑒H+ . The meta gene’s
expression is calculated as
log(𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒, ) = log(𝑔𝑒𝑛𝑒H ) + log(𝑔𝑒𝑛𝑒H0 ) − log(𝑔𝑒𝑛𝑒H+ ) + 𝐶H ,
where 𝐶H is a constant to make log(𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒, ) non-negative. The log transformation is
used to rescale expression and make the expression levels comparable across different
genes. We have found that including negative genes can strengthen spatial expression
pattern for domains that do not have enriched positive marker genes. This algorithm can
be used iteratively to find additional genes to form an updated meta gene with a clearer
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spatial pattern for the target domain. For the (𝑡 + 1)/I iteration, the meta gene
expression is calculated as
log(𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/0, ) = log(𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/ ) + log(𝑔𝑒𝑛𝑒/0 ) − log(𝑔𝑒𝑛𝑒/+ ) + 𝐶/
In the (𝑡 + 1)/I iteration, after adding 𝑔𝑒𝑛𝑒/0 and subtracting 𝑔𝑒𝑛𝑒/+ , SpaGCN will select
the (𝑡 + 1)/I control group based on 𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/0, . The size of the new control group,
which is the number of spots not in the target domain but have higher expression of
𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/0, than spots in the target domain, should be smaller than the size of the 𝑡 /I
control group, to ensure that 𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/0, has a clearer spatial pattern than
𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/ . Also, 𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/0, is expected to have a larger difference of mean
expression between the target and control groups than 𝑚𝑒𝑡𝑎_𝑔𝑒𝑛𝑒/ . Therefore, at each
iteration, SpaGCN checks whether both criteria are met, and the search of additional
genes will stop otherwise. An illustration of this iterative meta gene search is shown in
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Fig. 3.2.

Figure 3. 2: Illustration of the iterative search of meta gene with spatial gene expression enrichment using
the LIBD human dorsolateral pre-frontal cortex dataset (slice 151673).

3.2.7. Evaluation of Spatially Variable Genes using Moran’s I and Geary’s C Statistics
Gene expressions at different locations may not be independent. For example, the
expression levels of a gene at nearby locations may be closer in value than expression
levels at locations that are farther apart. This phenomenon is called spatial
autocorrelation, which measures the correlation of a variable with itself through space.
To evaluate whether the detected SVGs exhibit organized spatial expression pattern, we
used Moran’s I and Geary’s C, two commonly used statistics to quantify the degree of
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spatial autocorrelation of gene expression. Spatial autocorrelation can be positive or
negative. Positive spatial autocorrelation occurs when similar values occur near one
another. Negative spatial autocorrelation occurs when dissimilar values occur near one
another. Moran’s I metric [117] is a correlation coefficient that measures the overall
spatial autocorrelation of a dataset. Intuitively, for a given gene, it measures how one
spot is similar to other spots surrounding it. If the spots are attracted (or repelled) by
each other, it implies the spots are not independent. Thus, the presence of
autocorrelation indicates spatial pattern of gene expression. The Moran’s I value ranges
from –1 to 1, where a value close to 1 indicates a clear spatial pattern, a value close to 0
indicates random spatial expression, and a value close to –1 indicates a chess board like
pattern. To evaluate the spatial variability of a given gene, we calculate the Moran’s I
using the following formula,

𝐼=

𝑁 ∑) ∑&[𝑤)& (𝑥) − 𝑥̅ )(𝑥& − 𝑥̅ )]
,
∑)(𝑥) − 𝑥̅ )*
𝑊

where 𝑥) and 𝑥& are gene expression of spots 𝑖 and 𝑗, 𝑥̅ is the mean expression of the gene,
𝑁 is the total number of spots, 𝑤)& is spatial weight between spots 𝑖 and 𝑗 calculated using
the 2-dimensional spatial coordinates of the spots, and 𝑊 is the sum of 𝑤)& . For each
spot, we select the 𝑘 nearest neighbors using spatial coordinates. Moran’s I statistic is
robust to the choice of 𝑘 and is set at 4 in our analysis. We assign 𝑤)& = 1 if spot 𝑗 is in
the nearest neighbors of spot 𝑖, and 𝑤)& = 0 otherwise.
Geary’s C is another commonly used statistic for measuring spatial autocorrelation. It is
calculated as
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*
𝑁 ∑) ∑&[𝑤)& (𝑥) − 𝑥& ) ]
𝐶=
,
∑)(𝑥) − 𝑥̅ )*
2𝑊

The value of Geary’s C ranges from 0 to 2. To make it on the same scale as Moran’s I, we
convert it to the [−1, 1] scale by
𝐶 ∗ = 1 − 𝐶,
where 1 indicates perfect positive autocorrelation, 0 indicates no autocorrelation, and -1
indicates perfect negative autocorrelation. For each gene, the values of Geary’s C are
similar but not identical to Moran’s I.
3.2.8. Transferability of SpaGCN Detected SVGs
A genuine SVG should show transferability, that is, the spatial expression pattern should
be similar across different datasets collected from the same tissue type. To show the
transferability of SpaGCN detected SVGs, first, we show that the SVGs detected in one
dataset also show similar spatial expression patterns in an independent dataset. Second,
we show that SVGs detected in one dataset can be used to cluster spots in an
independent dataset and achieve relatively high clustering accuracy.
3.2.9. Comparison with Other Methods
To evaluate the performance of SpaGCN in identifying spatial domains, we compare with
Louvain, BaysSpace, stLearn, and HMRF. We use the default parameter settings for all
methods and the same number of clusters in clustering. To evaluate the performance of
SpaGCN in detecting SVGs, we compare with SPARK and SpatialDE. We initially detect
SVGs using their default parameter settings. By default, both SPARK and SpatialDE filter
out spots with total UMI counts less than 10. In SPARK, genes expressed in less than
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10% of the spots are filtered out. In SpatialDE, genes expressed in less than 3 spots are
filtered out. To evaluate the impact of filtering criteria on SPARK and SpatialDE, we
further eliminate genes expressed in less than 20% of the spots. The specificity of spatial
expression patterns of detected SVGs are evaluated by Moran’s I and Geary’s C statistics.

3.3. Results
3.3.1. Overview of SpaGCN and Evaluation
We explain the workflow of SpaGCN using in situ capturing-based SRT data as an
example, but the method can be easily modified to analyze other types of SRT data. As
shown in Fig. 3.3a, SpaGCN first builds a graph to represent the relationship of all spots
considering both spatial location and histology information. Next, SpaGCN utilizes a
graph convolutional layer to aggregate gene expression information from neighboring
spots. Then, SpaGCN uses the aggregated expression matrix to cluster spots using an
unsupervised iterative clustering algorithm [113]. Each cluster is considered as a spatial
domain from which SpaGCN then detects SVGs that are enriched in a domain by
differential expression analysis (Fig. 3.3b). When a single gene cannot mark the
expression pattern of a domain, SpaGCN will construct a meta gene, formed by the
combination of multiple genes, to represent the expression pattern of the domain.
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Figure 3. 3: Workflow of SpaGCN.

To showcase the strength of SpaGCN, we applied it to seven publicly available datasets
(Table 3.1). The spatial domains identified by SpaGCN agree better with known tissue
structures than Louvain, stLearn, and BayesSpace. We also compared SVGs detected by
SpaGCN with those detected by SpatialDE and SPARK, and found that the SpaGCN
detected SVGs have more coherent expression patterns and better biological
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interpretability than the other two methods. The specificity of spatial expression patterns
revealed by SpaGCN detected SVGs were further confirmed by Moran’s I and Geary’s C
statistics [117], two commonly used metrics for quantifying spatial autocorrelation of
gene expression [56, 118].
Table 3. 1. Datasets analyzed in SpaGCN.

Species

Tissue

Data Source

Protocol

Moncada et al. [119]
GSE111672

Dataset
Dimensions
224 spots
16,448 genes

Human

Primary
pancreatic cancer
tissue

Human

Dorsolateral
prefrontal cortex

Maynard et al. [120]
(http://research.libd.org/
spatialLIBD/)

Slice 151673:
3,639 spots
33,538 genes

10X
Visium

Mouse

Posterior brain
(sagittal)

10x Genomics
(https://support.10xgeno
mics.com/spatial-geneexpression/datasets/)

Mouse

Cortex

Stickels, R.R., et al. [121]
(https://singlecell.broadin
stitute.org/single_cell/stu
dy/SCP815/highlysensitive-spatialtranscriptomics-at-nearcellular-resolution-withslide-seqv2#studysummary)
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Spatial
Transcrip
tomics

Slice 151507:
4,226 spots
33,538 genes
3,353 spots
31,053 genes

10X
Visium

2560 spots
22683 genes

SLIDEseqV2

Mouse

Visual cortex

Mouse

Olfactory bulb

Mouse

Hypothalamus

Wang, X., et al. [119]
(https://www.dropbox.co
m/sh/f7ebheru1lbz91s/A
ADm6D54GSEFXB1feRy6
OSASa/visual_1020/2018
0505_BY3_1kgenes?dl=0
&subfolder_nav_tracking
=1)
Ståhl et al. [5]
(https://drive.google.com
/drive/folders/1C4l3lBaYl
7uuV2AA2o0WDzO_mkc_
b0pv?usp=sharing)

1207 cells
1020 genes

STARma
p

262 spots
16,218 genes

Spatial
Transcrip
tomics

Moffitt et al. [6]
GSE71585

5,665 cells
161 genes

MERFISH

3.3.2 Application to Human Primary Pancreatic Cancer ST Data
To demonstrate the importance of incorporating histology information, we analyzed a
human primary pancreatic cancer dataset generated using the ST technology [42]. This
dataset includes 224 spots and 16,448 genes with 3 manually annotated tissue regions.
The cancer region detected by Louvain based on gene expression alone did not closely
match the pathologist annotated cancer region (Fig. 3.4a). Spatial clustering methods
such as stLearn and BayesSpace did not detect the cancer region either. SpaGCN
revealed a similar pattern when using default parameters. Since the histology image
shows clear difference between the cancer and non-cancer regions, it suggests histology
is informative for clustering. SpaGCN has the flexibility of modeling histology with a
scaling parameter 𝑠, which controls the weight given to histology when detecting
neighbors for each spot. By increasing the value of 𝑠 from 1 to 2, SpaGCN detected a
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cluster that agrees well with the manually annotated cancer region. It is worth noting
that when 𝑠 was set at the default value of 1, SpaGCN detected the non-cancer regions
well. When 𝑠 was increased to 2, SpaGCN not only maintained the ability to detect the
non-cancer regions, but also detected the cancer region. This example showed that
SpaGCN is flexible in incorporating histology information in clustering. Although
stLearn can incorporate histology data, its use of histology information is pre-fixed by
the radius when defining neighboring spots. The lack of flexibility in adjusting histology
weight led to the discrepancy between their clustering and the pathologist’s manual
annotation.
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Figure 3. 4: Spatial domains and SVGs detected in the human primary pancreatic cancer tissue data.

Next, we detected SVGs using SpaGCN, SPARK, and Spatial DE. In total, SpaGCN
detected 12 SVGs, with 3, 8, and 1 SVGs for domains 0, 1, and 2, respectively (Fig. 3.4b).
Furthermore, a meta gene using KRT17, MMP11, and SERPINA1 marked the cancer
region better than the originally identified KRT17 for domain 2 (Fig. 3.4c). KRT17
functions as a tumor promoter and regulates proliferation in pancreatic cancer [122],
65

and MMP11 has been found to be a prognostic biomarker for pancreatic cancer [123].
Our identification of KRT17 and MMP11 as the two positive genes for the cancer region
agrees well with pancreatic cancer biology. SPARK and SpatialDE detected 203 and 163
SVGs, with their p/q values highly skewed toward 0. However, the Moran’s I and Geary’s
C values for their SVGs are much lower than those detected by SpaGCN, suggesting their
lack of spatial patterns (Fig. 3.4d). Furthermore, genes with smaller p/q values do not
necessarily show better spatial expression patterns than those with larger p/q values.
More stringent filtering of spots and genes did not improve the spatial pattern for
SpatialDE and SPARK detected SVGs.
3.3.3. Application to Human Dorsolateral Prefrontal Cortex 10x Visium Data
To quantitatively show that SpaGCN outperforms Louvain, stLearn, and BayesSpace in
spatial domain detection, we analyzed the LIBD human dorsolateral prefrontal cortex
(DLPFC) data generated using 10x Visium[124]. This study sequenced 12 tissue slices
that span six neuronal layers plus white matter from the DLPFC in 3 human brains. The
manual annotation of the tissue layers provided by the original study allows us to
evaluate the accuracy of spatial domain detection. Fig. 3.5a shows that for the
representative tissue slice 151673, both SpaGCN and BayesSpace revealed spatial
domains that agree better with the manually annotated tissue layers than Louvain.
Although stLearn utilized histology information, its performance is not much better than
Louvain and is substantially worse than SpaGCN and BayesSpace. The relative
performance of these methods remains the same when considering all 12 slices (Fig.
3.5b); the median ARI is 0.36 for stLearn, 0.42 for BayesSpace, and 0.45 for SpaGCN.
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Figure 3. 5: Spatial domains and SVGs detected in the LIBD human dorsolateral prefrontal cortex data.
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To further validate the identified spatial domains, we detected SVGs for each domain in
slice 151673. In total, SpaGCN detected 67 SVGs, with 53 of them being specific to
domain 5, which corresponds to white matter. Patterns of SVGs for other domains are
not very clear. These results indicate that gene expression profiles of spots from white
matter are distinct from spots in the neuronal layers, while gene expression differences
among the six neuronal layers are much smaller and more difficult to distinguish using
individual marker genes. SVGs detected by SPARK and SpatialDE also suffered from the
same problem. SPARK detected 3,187 SVGs with 1,131 of them having FDR-adjusted pvalues equal to 0, most of which only marked the white matter region. We also found
that the SVGs detected by SPARK lack domain specificity. SpatialDE detected 3,654
SVGs with 806 of them having q-values equal to 0, but these genes do not necessarily
show better spatial pattern than genes with larger q-values. Although SPARK and
SpatialDE detected much larger numbers of SVGs than SpaGCN, the genes detected by
these two methods lack the ability to distinguish different degrees of spatial expression
variability as their p/q-value distributions are highly skewed toward 0. Fig. 3.5c shows
that the Moran’s I values for SpaGCN detected SVGs are significantly higher than genes
detected by SpatialDE and SPARK (median of 0.39 for SpaGCN against 0.09 for SPARK
and 0.08 for SpatialDE). More stringent filtering of spots and genes didn’t improve the
performance of SpatialDE and SPARK. For 3 out of the 6 neuronal layers, SpaGCN
detected a single SVG to mark that region (Fig. 3.5d). For example, CAMK2N1 is
enriched in domain 0 (layer 1 and 2), PCP4 is enriched in domain 1 (layer 4), and NEFM
is enriched in domain 3 (layer 3).
To show that SpaGCN detected SVGs are useful for downstream analysis, we performed
K-means clustering on slice 151507, which is from a different brain, using all 67 SVGs
detected from slice 151673 by SpaGCN. Compared with manually curated layer
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assignment, this clustering analysis had an ARI of 0.23 (Fig. 3.5e,f). We performed
similar analysis using SVGs detected by SpatialDE and SPARK. When randomly
selecting 67 SVGs with 0 p/q-value from genes detected by SpatialDE/SPARK, the ARI is
only 0.13 for SpatialDE and 0.14 for SPARK. The ARIs for SpatialDE and SPARK did not
improve even with increased numbers of SVGs (Fig. 3.5e). These results further
confirmed the lack of spatial patterns for genes detected by SPARK and SpatialDE.
Although it is difficult to identify single genes to mark certain neuronal layers, SpaGCN
was able to find domain-specific meta genes. As shown in Fig. 3.5g, SpaGCN detected
meta genes for domains 1, 2, 4, and 6. The meta gene for domain 2 is specific to layer 1.
Since layer 1 only has a few spots, it is difficult to find a highly enriched gene. However,
by adding depleted genes like FTH1, MBP, MT-CO3, and PLP1, the expression pattern in
this region is strengthened. Furthermore, the SVGs and meta genes detected by SpaGCN
are transferrable to slice 151507 obtained from a different brain in which the meta genes
detected in slice 151673 mark the same layers in slice 151507 (Fig. 3.5g).
3.3.4. Application to Mouse Posterior Brain 10x Visium Data
Next, we analyzed a 10x Visium dataset generated from mouse posterior brain that
includes 3,353 spots and 31,053 genes [125]. This dataset shows much more complex
tissue structure than the previous two datasets. We compared the clustering result of
SpaGCN with Louvain, stLearn, and BayesSpace when the number of clusters was set at
10 for all methods. Fig. 3.6a shows that Louvain’s clustering is similar to stLearn,
BayesSpace, and SpaGCN, but the spatial domains detected by the latter three methods
are more spatially contiguous due to their ability to account for spatial dependency of
gene expression.
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Figure 3. 6: Spatial domains and SVGs detected in the mouse brain posterior brain data.
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We further investigated the ability of each method in detecting more refined tissue
structure. Specifically, we performed subclustering analysis for spots in domain 5
detected by SpaGCN, which corresponds to the cortex (Fig. 3.6b). The subdomains
detected by SpaGCN agree well with the Allen Brain Institute reference atlas diagram of
the mouse cortex (Fig. 3.6c). The detected subdomains include layers 2/3, layers 4/5,
layer 6, a hippocampal region (CA1), and the subiculum. Layers 2/3 are the “external”
cortical layers that are biologically responsible for local networks in which neurons in
this subdomain communicate to other neurons in adjacent neocortical regions. Layers
4/5 are the “internal” cortical layers that are biologically responsible for longer range
neural networks. For example, the visual cortex, which corresponds to the neocortical
region, is responsible for receiving visual information from the lateral geniculate nucleus
that is far away. SpaGCN was able to separate the molecular (layer 1), external (2/3),
internal (4/5), and the plexiform (6) layers. More importantly, SpaGCN outperformed
Louvain and stLearn, which show combining of neocortical layers. SpaGCN also
outperformed BayesSpace in distinguishing between the plexiform layer (subdomain 1)
and the non-neocortical CA1 region of the hippocampus (subdomain 3). In contrast,
BayesSpace combined layer 6 of the neocortex with the non-neocortical CA1 layer of the
hippocampus.
Next, we compared SpaGCN with SPARK and SpatialDE for SVG detection. SpaGCN
detected 1,028 SVGs for the 10 spatial domains while SPARK and SpatialDE detected
9,678 and 12,676 SVGs, respectively. As shown in Fig. 3.6d, the Moran’s I values of
SpaGCN detected SVGs are much higher than those detected by SPARK and SpatialDE
(median of 0.54 for SpaGCN against 0.20 for SPARK and 0.16 for SpatialDE). More
stringent filtering of spots and genes did not improve the performance of SPARK and
SpatialDE. The p/q-value distributions of SpatialDE and SPARK are highly skewed
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toward 0. and genes with similar p/q-values do not necessarily show similar spatial
pattern and a smaller p/q-value doesn’t guarantee a better spatial pattern. In contrast,
multiple domain adaptive filtering criteria implemented in SpaGCN allow it to eliminate
false positive SVGs and ensure all detected SVGs to have clear spatial expression
patterns.
To illustrate how the filtering in SpaGCN works, we use domains 1, 5, and 8 as an
example. For each of these domains, SpaGCN detected a single SVG enriched in that
region. As shown in Fig. 3.6e, PVALB is enriched in domain 1, and TRM62 is enriched in
domain 8. Although domains 1 and 8 are adjacent to each other, these two SVGs can still
well mark these domains. NRGN is a SVG that SpaGCN detected for domains 5 and 7.
The high expression of NRGN in domains 5 and 7 also indicate that these two domains
are neuroanatomically similar – both consisting of cortex and the pyramidal layer of the
hippocampus. Both the cortex and hippocampus are regions that are on the curved
surface of the brain. Domains 5 and 7, which would be contiguous in a 3D
reconstruction, are artifactually separated due to how the section was cut. Therefore, it is
not surprising that in addition to NRGN, SpaGCN also detected many other SVGs for
domain 5 and 7, some of which are highly expressed in both domains. The unique and
powerful SVG detection procedure in SpaGCN ensures that genes like these are not
missed.
SpaGCN only identified 4 SVGs for domain 0. However, we reason that a meta gene,
formed by the combination of multiple genes, may better reveal spatial patterns than any
single genes. We used domain 0 as an example to show how SpaGCN can create
informative meta genes to mark a spatial domain (Fig. 3.6f). First, by lowering the
filtering thresholds, SpaGCN identified KLK6 which is highly expressed in the lower part
of domain 0. Using KLK6 as a starting gene, SpaGCN used a novel approach to find a
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log-linear combination of gene expression of KLK6, MBP and ATP1B1, which accurately
marked the spatial domain 0. In this meta gene, KLK6 and MBP are considered as
positive markers because they are highly expressed in some spots in domain 0, whereas
ATP1B1 is considered a negative marker as it is mainly expressed in regions other than
domain 0. Previous studies have shown that KLK6 and MBP expression is restricted to
oligodendrocytes, while ATP1B1 is mainly expressed in neurons and astrocytes[121]. This
resonates the fact that domain 0 represents white matter which is dominated by
oligodendrocytes and has few neuronal cell bodies. Therefore, the genes that make up
this meta gene have meaningful biological interpretation.
While we focused our analyses on one tissue section, SpaGCN can also jointly analyze
multiple tissue sections. We show two examples using this mouse brain Visium data
provided by 10x Genomics. Fig. 3.7a shows SpaGCN clustering results for 2 mouse
posterior sections. Since these 2 tissue sections are from the same region, SpaGCN was
able to infer cluster correspondence between the two tissue sections. Next, we used
SpaGCN to jointly analyze two tissue sections with one from the mouse posterior brain
and the other from the mouse anterior brain. Since the anterior section and posterior
section are adjacent in the brain, we modified the coordinates for spots in the posterior
section such that the revised coordinates reflect the spatial adjacency of the two tissue
sections. Using the modified coordinates as input, SpaGCN was able to produce
clustering results that reflect the shared layer structure in the anterior and posterior
brain (Fig. 3.7b).
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Figure 3. 7: Joint spatial domain detection across multiple mouse brain tissue sections using SpaGCN.

3.3.5 Application to Mouse Visual Cortex STARmap Data
Finally, we analyzed a STARmap dataset that has single-cell resolution [103]. This
dataset was generated from mouse visual cortex that spans from hippocampus, to corpus
callosum, and the six neocortical layers. In total, 1,020 genes were measured in 1,207
cells that include non-neuronal cells, excitatory, and inhibitory neurons. The layer
structure and cell type distribution of the tissue section provided by the original study
are shown in Figure 3.8a. Since the tissue capture area of STARmap is much smaller
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than 10x Visium, we increased the contribution of neighboring cells from 0.5 to 1 when
calculating the weighted gene expression of each cell in SpaGCN. Using this approach,
SpaGCN detected spatial domains that agreed well with the annotated tissue structure
(Fig. 3.8a,c), achieving an ARI of 0.51. By contrast, the ARIs of the other methods are
much lower (0.30 for Louvain, 0.37 for BayesSpace, and 0.03 for HMRF) (Fig. 3.8b).
This example demonstrates that SpaGCN utilizes spatial information more efficiently
than BayesSpace and HMRF. Using SpaGCN, we further detected 25 SVGs including
genes LAMP5, HPCAL1, CPLX1, PLP1, NRSN1, ATP1A2, and BSG that showed enriched
expression patterns for domains 0 to 6 (Fig. 3.8e). Similar to previous analyses, SPARK
and SpatialDE detected much larger number of SVGs but many of the SVGs lack spatial
expression patterns (Fig. 3.8d).
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Figure 3. 8: Spatial domains and SVGs detected in the mouse visual cortex STARmap data.
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3.4. Discussion
In this chapter, we presented SpaGCN, a method that integrates gene expression, spatial
location, and histology to model spatial dependency of gene expression for identification
of spatial domains and domain enriched SVGs. SpaGCN has been extensively tested on
datasets from different species, regions, and tissues generated using diverse SRT
technologies. We also performed additional analyses on ST [32], SLIDE-seqV2 [105],
and MERFISH [31] data. Our results consistently showed that SpaGCN can identify
spatial domains with coherent gene expression and histology and detect SVGs and meta
genes that have much clearer spatial expression patterns and biological interpretations
than genes detected by SpatialDE and SPARK. Additionally, the SpaGCN detected SVGs
are transferrable and can be utilized for downstream analyses in independent tissue
sections.
The spatial domain detection step in SpaGCN is flexible. First, SpaGCN can adjust the
weight of histology in gene expression smoothing. For datasets with clear tissue structure
in histology, higher weight led to clearer separation of cancer- vs non-cancer regions.
Second, during the GCN fitting procedure, the graph weights are updated, which allows
SpaGCN to learn an efficient way to aggregate gene expression from neighboring spots
for each gene. For data generated from different platforms, the spatial dependency
between spots/cells is different as the size of the captured tissue area varies. The
flexibility in modeling spatial dependency makes SpaGCN versatile for different types of
SRT data.
Finally, SpaGCN is computationally fast and memory efficient compared to SPARK and
SpatialDE. With the increasing popularity of SRT in biomedical research, we expect
SpaGCN will be an attractive tool for large-scale SRT studies.
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Chapter 4: TESLA: Deciphering tumor ecosystems at super-resolution from
spatial transcriptomics

4.1. Introduction
The tumor microenvironment (TME) contains networks of cells and structures that
surround tumor cells [126]. Tumor-TME crosstalk regulates the initiation, progression,
and metastasis of tumors [127]. A comprehensive analysis of the multiple exchanges
between tumor cells and their TME is essential for understanding the underlying
mechanisms of tumor growth and response to therapy. The TME has a great impact on
the efficacy of anti-cancer therapies and clinical outcomes [128, 129]. For example,
hypoxic avascular regions deeply embedded inside the tumors significantly hinder the
delivery of therapeutic agents [130], and hypoxic tolerant tumor cells are resistant to
most anti-cancer treatments [131, 132].
Tumor infiltrating lymphocytes (TILs) consist of lymphocytic cell populations that have
invaded the tumor tissue and have emerged as an important biomarker in predicting the
efficacy and outcome of anti-cancer treatment [133, 134]. Recent studies suggest that not
only the density of TILs, but also their spatial organization, such as the presence of
tertiary lymphoid structures (TLSs), play key roles in determining tumor immune
phenotypes and response to immunotherapy [135]. TLSs are broadly found in the TME
for various solid cancers. Similar to secondary lymphoid organs, mature TLSs are
believed to be the site of immune response activation against tumor by recruiting and
activating TILs and represent the key to understanding antitumor immune responses.
Spatial transcriptomics (ST) enables gene expression profiling while preserving location
information in tissues, which innovates a promising avenue to understand the spatial
context and the nature of cellular heterogeneity of the TME [136-138]. In a ST
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experiment using spatial barcoding followed by next-generation sequencing-based
technologies such as Spatial Transcriptomics [32] and 10x Genomics Visium, the
expression levels for thousands of genes in a tissue section are simultaneously measured,
complemented by a high-resolution histology image obtained from the same tissue
section. With the power of ST, we aim to provide a detailed annotation of tumor
structure and different lymphocytes by integrating gene expression and histology image
information.
A major challenge that hinders gene expression and histology integration in spatial
barcoding-based ST is the relatively low resolution of gene expression data compared to
histology images, which prevents deciphering detailed TME structures such as the TLS.
Although methods such as BayesSpace [46] can enhance the gene expression resolution,
their enhancement is only for regions captured by spots, but still leaves a large portion of
the tissue unmeasured for gene expression. A recently developed method, XFuse [139],
uses a deep generative model to predict super-resolution gene expression at each pixel by
leveraging information in hematoxylin and eosin (H&E)-stained histology images.
However, XFuse is extremely slow – often takes more than two weeks to analyze a tissue
section generated from 10x Visium on a GPU machine. Additionally, its prediction
accuracy heavily depends on the similarity between the spatial patterns of gene
expression and the histology image. For many genes that are responsible for immune
response, their spatial patterns are weakly correlated with histology images, making
XFuse less applicable when the goal is to decipher the TME.
To overcome the above-mentioned challenge, we present TESLA (Tumor Edge Structure
and Lymphocyte multi-level Annotation), a machine learning framework that integrates
gene expression and histology image information in ST to investigate the TME. By
generating super-resolution gene expression images, TESLA can leverage histology
79

information to annotate different tumor/TME cell types on the histology image with
pixel-level resolution, detect TIL structure such as TLS by colocalization analysis of
different lymphocytes and dendritic cells, and characterize high-resolution cellular and
molecular spatial structures of tumor by separating tumor edge and core and elucidating
differential transcriptome programs between the edge and core. The detailed multi-level
annotations performed by TESLA provide a comprehensive understanding of the TME.

4.2. Materials and Methods
4.2.1. Data Preprocessing
TESLA takes spatial gene expression and histology image data as input. The spatial gene
expression data contain an 𝑁 × 𝐺 matrix of unique molecular identifier (UMI) counts
with 𝑁 spots and 𝐺 genes, along with the (𝑥, 𝑦) 2-dimensional spatial coordinates of each
spot. The gene expression values in each spot are normalized such that the UMI count
for each gene in a given spot is divided by the total UMI count across all genes in that
spot, multiplied by 10,000, and then transformed to a natural log scale.
4.2.2 Super-resolution Gene Expression Image Generation
After preprocessing, TESLA extracts the measured tissue region from the histology
image and generates a super-resolution gene expression image for each gene in the tissue
using histological, spatial location, and the original spot-level gene expression data.
Below we describe each step in super-resolution gene expression generation in detail.
4.2.2.1. Superpixel Generation
TESLA first detects the contour of the captured tissue area in the histology image. When
the tissue region can be easily separated from the histology image background, TESLA
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uses the Canny-edge-detection algorithm implemented in the python package “opencv”
to draw the contour. When the histology image contains contaminated stains or tissue
fragments, the Canny-edge-detection algorithm may result in an inaccurate contour. In
this case, TESLA detects the boundary of the measured spots and uses the enlarged
boundary as the tissue contour. After contour detection, TESLA separates the tissue
region inside the contour into equal-sized squares, referred to as superpixels. The size of
the superpixels can be adjusted depending on the dataset and is usually much smaller
than spots captured by next generation sequencing-based ST technologies. The default
size of a superpixel is 50 × 50 pixels, but can be adjusted by user depending on the
diameter size of each spot in the ST data. As a comparison, the diameter is ~350 pixels
for a Spatial Transcriptomics spot and ~200 pixels for a 10x Visium spot.
4.2.2.2 Superpixel Gene Expression Imputation
We aim to impute the gene expression at each superpixel using observed spot-level gene
expression. The gene expression of a superpixel is expected to be similar to that of its
neighboring spots. Thus, to impute the gene expression at a given superpixel 𝑣, TESLA
detects its top 10 nearest neighboring measured spots based on the Euclidean distance
metric described in SpaGCN [47], which considers the similarity between the superpixel
𝑣 and a measured spot with respect to both physical location and histological features.
We first extract the approximate region of each superpixel on the histology image and
calculate the mean color value for the RGB channels, (𝑟@ , 𝑔@ , 𝑏@ ), of all pixels that fall in
that region. Next, a weighted sum of the RGB value is calculated to represent the
histology image features,

𝑧@ =

𝑟@ × 𝑉< + 𝑔@ × 𝑉> + 𝑏@ × 𝑉4
,
𝑉< + 𝑉> + 𝑉4
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where 𝑉< = Variance(𝑟@ ), 𝑉> = Variance(𝑔@ ), and 𝑉4 = Variance(𝑏@ ) for all 𝑣 ∈ 𝑉. Then, 𝑧@
is rescaled to the same scale as 𝑥D and 𝑦D as
𝑧@∗ =

𝑧@ − 𝜇6
× maxI𝜎B , 𝜎C J ,
𝜎6

where 𝜇6 is the mean of 𝑧@ , 𝜎B , 𝜎C , 𝜎6 are the standard deviations of 𝑥D , 𝑦D
and 𝑧D , respectively. The 3D coordinates for all the measured spots are derived in the
same approach, and the Euclidean distance between superpixel 𝑣 and a measured spot 𝑢
is calculated as
𝑑(𝑢, 𝑣) = }(𝑥E − 𝑥@ )* + (𝑦E − 𝑦@ )* +(𝑧E∗ − 𝑧@∗ )* .
For each superpixel 𝑣, TESLA detects its top 10 nearest neighboring measured spots,
denoted as set 𝑁@ . Then, the gene expression value of the superpixel 𝑣 is imputed using a
weighted sum of the neighboring spots’ gene expression values. The weight for a given
neighboring spot 𝑢) ∈ 𝑁@ is negatively associated with the distance from that spot to the
superpixel and is defined as

𝑤(𝑢) , 𝑣) =

𝑑(𝑢) , 𝑣)+*

+* ,

∑E! ∈G& 𝑑I𝑢& , 𝑣J

where 𝑑(𝑢) , 𝑣) is the Euclidean distance calculated using the approach described in
SpaGCN. For a given gene 𝑔, its imputed expression value for superpixel 𝑣 is calculated
as

𝑒>,@ = P

E# ∈G&

𝑤(𝑢& , 𝑣) 𝑒>,E! ,
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where 𝑒>,E! is the measured spot-level gene expression for gene 𝑔 at spot 𝑢) . For each
pixel within the superpixel, its expression is imputed as the gene expression at the
corresponding superpixel.
After imputation, TESLA generates a super-resolution gene expression image for each
gene in the tissue with tissue gaps imputed as well. We note that the center-to-center
distance between two adjacent spots in the current 10x Visium platform is 100 µm,
leaving a large portion of the tissue unmeasured for gene expression. Although
BayesSpace can enhance the gene expression resolution within measured spots, regions
that are not covered by spots are still left blank.
4.2.3 Multi-level Tissue Annotation
TESLA can annotate a tissue section at multiple levels by integrating different superresolution gene expression images together with a histology image for joint segmentation
using a convolutional neural network approach. For example, using integrated cell-typespecific marker gene images and the histology image as input, TESLA can reveal cell type
distributions at the same pixel-level resolution as the histology. Additionally, TESLA can
identify tumor regions if the tumor marker gene images are used as input for joint
segmentation. The joint consideration of tumor marker genes and histology images
enables the detection of intra tumor heterogeneity that might be missed by traditional
pathology-based tumor diagnosis. For simplicity, we use cell type annotation to
demonstrate the annotation method.
4.2.3.1. Generation of Meta Gene Image
The joint segmentation takes both gene expression and histology images as input. A
histology image has 3 color channels representing red (R), green (G), and blue (B) color
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intensities, while the gene expression are represented by 𝐾 channels for a cell type with
𝐾 marker genes. If the channels are weighted equally, the gene expression would
dominate the joint segmentation results when 𝐾 is larger than 3, whereas the histology
image would dominate when 𝐾 is less than 3. Therefore, it is important to find a balance
between the histology and gene expression. Since the number of marker genes varies
across cell types, we combine the 𝐾 markers into one meta marker gene, which can be
represented by one color channel, to make our method robust across different cell types.
Since not all marker genes are expressed, an ideal meta gene should preserve the
expression pattern for at least a subset of the marker genes. Given 𝐾 marker genes and a
pre-specified number 𝑘, for any superpixel 𝑖, we first rank all markers’ relative
expression in descending order as {𝑒,,), 𝑒*,), 𝑒K,),… 𝑒F,), }. Next, we select the top 𝑘
expression values and calculate the meta gene’s relative expression at superpixel 𝑖 as:
𝑒'9/=,) = 𝑚𝑖𝑛(𝑒,,) , 𝑒*,) … 𝑒.,) ).
At a given superpixel, if only the top 𝑘 − 1 or fewer marker genes are expressed and the
𝑘/I marker has zero expression, the meta gene will have an estimated expression value of
0 at that superpixel. This step ensures that expression patterns that are present in less
than 𝑘 genes are not included in the meta gene, thus avoiding generating patterns that
are less representative. Defining the meta gene’s expression in this way guarantees that
its expression level is high at a given superpixel if and only if all top 𝑘 markers are highly
expressed at that superpixel. In our analyses, we set 𝑘 equal to 1 to capture the
expression patterns of all marker genes.
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4.2.3.2 Tissue Segmentation Using Convolutional Neural Network
Next, we convert the RGB channels from the histology image into one gray channel. For
the meta gene image, we use the gene expression at each superpixel to represent the
expression for each pixel that resides within the superpixel. Since the gray and meta gene
channels are the same size, we can simply stack them to create a 2-channel image, where
each pixel value is normalized to [0, 1] and fed into a convolutional neural network for
unsupervised segmentation[140] (Fig. 4.1). Let 𝑀 be the number of pixels in the 2# N
channel image denoted by 𝐼 = {𝑣' ∈ 𝑅* }N
'-, . A p-dimensional feature map {𝑥' ∈ 𝑅 }'-,

is computed from {𝑣' }N
'-, through two convolutional components, each of which
consists of a 2-dimensional convolution, a ReLU activation function, and a batch
normalization function. Subsequently, a response map {𝑟' = Λ𝑥' }N
'-, is obtained by
#×#
applying a linear classifier on {𝑥' ∈ 𝑅# }N
represents the weights in
'-, , where Λ ∈ 𝑅

the convolutional layer. The response map is then normalized to {𝑟'( }N
'-, , which has zero
mean and unit variance. Finally, the initial cluster label 𝑐' for each pixel is obtained by
selecting the cluster that has the maximum value in 𝑟'( . To initialize the neural network,
we start with a large initial number of clusters (default 𝑝 = 100).

Figure 4. 1: Architecture of the CNN for image segmentation in TESLA.
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The loss function 𝐿 consists of a constraint on spatial continuity and a constraint on gene
expression similarity, defined as follows,
𝐿 = 𝜇𝐿?;! ({𝑟'( }) + 𝐿>9!9 ({𝑟'( , 𝑐' }),
where 𝜇 represents the weight for balancing the two constraints (𝜇 = 5 as default).
Following Kim et al. [141], we utilize the L1-norm of horizontal and vertical differences of
the response map {𝑟'( }N
'-, as a spatial constraint, which is defined as
P+,
(
(
(
(
𝐿?;! ({𝑟'( }) = ∑Q+,
O-, ∑I-, (B𝑟O0,,I − 𝑟O,I B, + B𝑟O,I0, − 𝑟O,I B, ) ,

(
where 𝑊 and 𝐻 represent the width and height of the 2-channel image, and 𝑟O,I

represents the pixel value at (𝑤, ℎ) in the response map {𝑟'( }N
'-, . By applying this spatial
continuity loss, an excessive number of clusters due to complicated patterns can be
N
suppressed. The following cross entropy loss between {𝑟'( }N
'-, and {𝑐' }'-, is calculated

as the constraint on gene expression similarity,
#
(
𝐿>9!9 ({𝑟'( , 𝑐' }) = ∑N
'-, ∑)-, −𝛿(𝑖 − 𝑐' ) log 𝑟',) ,

where 𝛿(⋅) is an indicator function. This loss ensures that pixels assigned to the same
cluster have similar meta gene expression.
In the iterative update procedure, cluster memberships for spatially close pixels or pixels
with similar meta gene expression values are merged by considering spatial continuity
and gene expression similarity. This process leads to the reduction in the number of
unique clusters 𝑝( . The normalized response map vectors and cluster assignments are
updated iteratively as follows. Since some clusters may have no pixels assigned to them,
the number of unique clusters can be a number 𝑝( ranging from 1 to 𝑝. During each
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training epoch, TESLA has a cluster refinement step to merge minor clusters to its
neighboring major clusters. First, clusters containing less than 1000 (default) pixels will
be selected as minor clusters. Next, for each pixel in a given minor cluster, its
neighboring pixels, defined as pixels located within a circle of radius 3 centered at that
pixel, are collected into a set. Based on the cluster identities of all neighboring pixels of
the pixels in that minor cluster, TESLA will detect the major cluster which has the most
pixels in the neighboring set, referred to as the neighboring major cluster. TESLA then
merges the minor cluster with its neighboring major cluster, which increases the
integrity of the segmentation. Due to the cluster refinement step, the number of clusters
decreases during the training process. The model will stop training when the number of
clusters reaches a pre-defined threshold (default is 30). We tested the value of this
threshold from 10 to 50 and found that it does not significantly affect the target cell type
detection. We use 30 as default to allow the algorithm to assign some tissue edge and
small contaminated regions as small clusters.
4.2.3.3 Target Cell Type Detection
After obtaining the cluster assignments from segmentation, TESLA identifies which
cluster(s) are enriched for a specified target cell type. Since the segmentation output has
the same resolution as the meta gene image, TESLA can calculate the average meta gene
relative expression across all pixels within each cluster and sort the clusters in
descending order of this value as ˜𝑒̅'9/=,?RES/9<, , 𝑒̅'9/=,?RES/9<* , … , 𝑒̅'9/=,?RES/9<# ™. Next,
clusters whose average meta gene relative expression is greater than 𝑡 × 𝑒̅'9/=,?RES/9<, are
considered as clusters that are enriched for the target cell type. We find that 𝑡 = 1/2
generally generates the best performance in practice. Finally, each cluster is annotated
on the histology image with color corresponding to the average meta gene expression
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level. This framework is flexible, where users can customize their own gene list for a cell
type of interest; for example, by changing the cell type marker genes to tumor marker
genes, one can detect the tumor region in the tissue. All the marker genes used are listd
in Table 4.1.
Table 4. 1. Marker genes used for cell type, tumor region and protein detection.

Target region
B cell
CD8+ T cell
Follicular helper T cells
Dendritic cell
CXCL13
Melanoma
Squamous cell carcinoma
Breast Cancer
HER2+ tumor subtype
ER+ tumor subtype
PgR+ tumor subtype

Marker genes
CD19, CD79A, CD79B, MS4A1, CD22
CD8A, CD8B
CD3E, CD3D, CD3G, CD4, PDCD1, CXCR5
CD1A, CD1B, CD1E, CLEC10A, CLIC2, WFDC21P
CXCL13
MITF, CSPG4, MAGEA1, MLANA, TYR, SOX10
BUB1B, KIF1C, TOP2A, CD151, MMP10, PTHLH,
FEZ1, IL24, KCNMA, INHBA, MAGEA4, NT5E,
LAMC2, SLITRK6
ERBB2, CNN1, CDH1, KRT5, KRT7, KRT14,
KRT18, CDNND1, GATA3, FOXA1, PIP, SCGB2A2
ERBB2
ESR1
PGR

4.2.4. Intra-tumor Heterogeneity Analysis
With tumor region annotation, we can further draw the leading edge and separate the
tumor into edge and core, which allows us to study intra-tumor heterogeneity. TESLA
first detects the boundary of the tumor region using the Canny-edge-detection algorithm
implemented in the python package “opencv”. Tumor edge is defined as the area that is
within 200 µm interface of tumor and adjacent to non-malignant tissue and the tumor
core is defined as the proximal tumor area within the tumor edge [141]. After the tumor
edge and core are identified, we can perform differential expression analysis to detect
genes enriched in the edge and the core, which will help in understanding the
heterogeneity inside the tumor.
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4.2.5. Detection of Tertiary Lymphoid Structure
Previous studies have suggested that TLS formation results from a complex interplay
between B cells, CD4+ T cells, and dendritic cells, with reciprocal signaling between
these cells mediated by chemokine CXCL13 [135]. TESLA detects the potential location
of TLS based on the colocalization of B cells, CD4+ T cells, dendritic cells, and
chemokine CXCL13. For any pixel 𝑖, TESLA first calculates the molecular abundance of
each cell type as the mean expression across all pixels for the corresponding meta gene of
that cell type. TELSA then ranks the molecular abundances of these cell types and
CXCL13 in descending order as {𝑏,,), 𝑏*,), 𝑏K,), 𝑏T,), }. Next, the TLS score is calculated as the
minimum value of the top three abundances:
𝑇𝐿𝑆 𝑠𝑐𝑜𝑟𝑒 ) = 𝑚𝑖𝑛(𝑏,,) , 𝑏*,) , 𝑏K,) ).
This minimum pooling from the top three values ensures that a pixel has a high TLS
score if and only if at least three out of the four abundances are high. We do not perform
minimum pooling using all four values because we expect the enrichment of B cells,
CD4+ T cells, and dendritic cells, and CXCL13 may be closely related to TLS but not
perfectly overlap with the other three cell types. Next, we annotate the whole tissue with
color corresponding to the TLS score, where dense regions embedded inside the tumor
with high TLS scores are identified as TLSs.
4.2.6. Comparing Image Similarity Using SSIM
The Structural SIMilarity (SSIM) index is a method for measuring the similarity between
two images. The SSIM between two images 𝑥 and 𝑦 of the same size is calculated as
(*3' 3( 0?) )×(*W'( 0?$ )

𝑆𝑆𝐼𝑀(𝑥, 𝑦) = X3$ 03$ 0?
'
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(

$
$
) Y×(W' 0W( 0?$ )

,

where (𝜇B , 𝜇C ) and (𝜎B , 𝜎C ) are the means and standard deviations of 𝑥 and 𝑦, 𝜎BC is the
covariance of 𝑥 and 𝑦, 𝑐, = (0.01 × 𝐿)* and 𝑐* = (0.03 × 𝐿)* are two variables used to
stabilize the division, and 𝐿 is the dynamic range of the pixel-values. When calculating
the SSIM between protein’s immunofluorescence staining image and the superresolution gene image, the protein staining intensity and the super-resolution gene
expression are scaled to the range (0, 255).

4.3. Results
4.3.1. Overview of TESLA and Evaluation
TESLA starts from enhancing the original spot-level gene expression in ST. As shown in
Fig. 4.2a, TESLA first detects the contour of the tissue area. Next, for each gene, TESLA
imputes each superpixel’s gene expression through weighted aggregation of spot-level
expression values from nearby spots and generates an expression image for the entire
histology image by filling in tissue gaps that are not covered by spots.
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Figure 4. 2: Workflow of TESLA.

91

With the super-resolution gene expression images generated for tumor, immune, and
stromal cells, TESLA can annotate the tumor region and tumor-immune interface at
multiple levels. To infer tumor cell distribution, TESLA first combines tumor related
marker genes into a meta gene that captures the shared expression patterns of the
markers (Fig. 4.2b). After stacking the meta gene images and the histology image as
input, TESLA then employs a convolutional neural network approach to segment the
tissue region in an unsupervised manner, which enables the annotation of the tumor
region directly on the histology image with pixel-level resolution. Since the tumor cells
and microenvironment at the invasive edge of tumor are known to be different from that
of the tumor core[127], TESLA also draws the leading edge along the tumor boundary
and outlines the tumor edge and tumor core (Fig. 4.2c).
To characterize spatial cellular and molecular heterogeneity between the tumor edge and
core and better understand tumor-TME dynamics, TESLA first performs differential
gene expression analysis between the edge and core, which enables the identification of
differentially expressed genes (DEGs) that are specific to the tumor edge or core regions.
With the region-specific DEGs, TESLA can also compare cell compositions and
transcriptome programs between the edge and core and further profile spatial
heterogeneity of the TME. In addition to tumor region annotation, TESLA can also
annotate a target cell type’s distribution on the histology image by using cell-typespecific marker genes, e.g., lymphoid cell lineage markers, as input (Fig. 4.2b). Based on
the colocalization of specific cell populations, TESLA can further detect multicellular
structures such as TLS (Fig. 4.2d).
To showcase the strength and properties of TESLA, we applied it to five publicly
available ST datasets (Table 4.2). First, we show that the super-resolution gene
expression correlates well with protein expression obtained from immunofluorescence
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staining. We further show that the cell type distribution predicted by TESLA agrees well
with independent cell type deconvolution results by RCTD [56], and the predicted TLSs
are in agreement with independent pathologist’s annotation.
Table 4. 2. Datasets analyzed in TESLA.

Species

Tissue

Data source

Dataset
dimensions

Human

Invasive
ductal
carcinoma

10x Genomics
4,727 spots
(https://support.1 36,601 genes
0xgenomics.com/s
patial-geneexpression/dataset
s/1.2.0/V1_Human
_Invasive_Ductal_
Carcinoma)[46]

10x Visium

Human

Cutaneous
squamous
cell
carcinoma

Ji et al.[142]
GSE144240

646 spots
17,344 genes

10x Visium

Human

Cutaneous
squamous
cell
carcinoma

Ji et al.[142]
GSE144240

6,824 cells
32,738 genes

10X Chromium
3' v2

NA

Human

Cutaneous
malignant
melanoma

Thrane et al.[40]
(https://www.spat
ialresearch.org/res
ources-publisheddatasets/doi-101158-0008-5472can-18-0747/)

293 spots
16,148 genes

Spatial
Transcriptomics

350
pixels
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Protocol

Spot
diamet
er by
pixels
172
pixels

200
pixels

Human

Melanoma
tumor

Tirosh et al.[120]
[https://science.sci
encemag.org/cont
ent/352/6282/189
]
GSE72056

4,139 cells
23,686 genes

Smart-Seq2

Human

HER2+, ER+
and PRbreast cancer

3,798 spots
36,601 genes

10x Visium

Human

HER2positive
breast tumor

10x Genomics
(https://support.1
0xgenomics.com/s
patial-geneexpression/dataset
s/1.1.0/V1_Breast
_Cancer_Block_A_
Section_1)[143]
Andersson et
al.[144]
(https://github.co
m/almaan/her2st)

295 spots
15,109 genes

Spatial
Transcriptomics

146
pixels

Mouse

Posterior
brain
(sagittal)

3,355 spots
32,285 genes

10x Visium

80
pixels

Mouse

Kidney
(coronal)

1,438spots
32,285genes

10x Visium

80
pixels

Human

Clear cell
renal cell
carcinoma
primary
tumors

10x Genomics
(https://support.1
0xgenomics.com/s
patial-geneexpression/dataset
s/)
10x Genomics
(https://support.1
0xgenomics.com/s
patial-geneexpression/dataset
s/)
Meylan et al.[145]
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4.3.2. Imputation of Super-resolution Gene Expression by Integrating Histology Image
Information
TESLA’s multi-level cellular and molecular annotation of ST data relies on the superresolution gene expression images. We conducted hold-off experiments on five public
datasets to show that TESLA can faithfully recover the missing expression patterns for
genes with spatial variability. For each dataset, we first selected Spatially Variable Genes
(SVGs) using our previously developed method, SpaGCN [47]. Next, we masked a
selected proportion of measured spots and used the remaining spots to impute the SVGs’
expression for the masked spots. Fig. 4.3a shows the correlation between the observed
and imputed SVGs’ expression of the masked spots. As the hold-off ratio decreased from
50% to 10%, the median correlation increased from 0.57 to 0.62 for the invasive ductal
carcinoma (IDC) dataset [46], from 0.65 to 0.76 for the cutaneous squamous cell
carcinoma (CSCC) dataset [43], from 0.70 to 0.79 for the cutaneous malignant
melanoma dataset [40], from 0.66 to 0.68 for the mouse posterior brain tissue dataset,
and from 0.52 to 0.58 for the mouse kidney dataset. These high correlations indicate that
TESLA can recover the underlying expression pattern for unmeasured spots. Since the
distances between superpixels and their nearest neighboring spots in real ST data are
smaller than the distances between the masked spots and their neighboring spots in the
hold-off experiments, we expect TESLA to perform better in real data analysis. We also
performed the same mask test using the top 2,000 highly variable genes.
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Figure 4. 3: Evaluation of super-resolution gene images from TESLA

To further evaluate the accuracy of TESLA’s imputed super-resolution gene expression,
we performed additional analysis on the IDC dataset, which is generated from an
estrogen receptor-positive (ER+), progesterone receptor-negative (PR-), human
epidermal growth factor receptor (HER)2-amplified (HER+) invasive ductal carcinoma
tissue section[146]. This tissue section has paired immunofluorescence staining for CD3ε
protein counterstained with 4,6-diamidino-2-phenylindolo (DAPI). We compared the
performance of TESLA with BayesSpace [46], a recently developed tool that can also
enhance the gene expression resolution for ST data. TESLA features two benefits relative
to BayesSpace because 1) TESLA can incorporate high-resolution histology image
information and offers more flexibility for resolution enhancement by adjusting the
superpixel size, while BayesSpace can only enhance the gene expression resolution by
splitting a spot into fixed number of subspots; 2) TESLA can fill in gene expression for
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unmeasured tissue regions between spots while BayesSpace leaves unmeasured tissue
areas blank. For 10x Visium, each spot is 55 µm in diameter with a 100 µm center to
center distance between spots. The lack of full tissue coverage by spots leaves
approximately 54% to 80% of the tissue unmeasured for gene expression.
An ideal gene expression enhancement method should increase the gene expression
resolution while retaining the original expression pattern at the spot level as this will
ensure no artificial patterns are introduced in the enhanced gene expression. To show
that TESLA outperforms BayesSpace in retaining the original gene expression patterns,
we considered the top 2,000 highly variable genes selected by BayesSpace and obtained
the spot-level gene expression from the enhanced expression generated from each
method. For TESLA, we obtained the spot-level gene expression from the superresolution gene expression image by extracting expression from a circle that exactly
overlaps the measured spots. For BayseSpace, we summed up the expression from all
sub-spots within a spot to get the spot-level expression. As shown in Fig. 4.3b, TESLA’s
super-resolution gene expression derived spot-level expression yields significantly higher
correlations with the original spot-level gene expression than BayesSpace (median: 0.54
vs 0.30, two-sample t-test P < 2.2e-16). Although BayesSpace requires the sum of
principal components of the subspots equals the principal component of the original
spot, it cannot guarantee the expression pattern is not distorted in the original gene
expression space .
Since the ground truth of gene expression is unknown, we cannot evaluate the accuracy
of the super-resolution gene expression directly. Instead, we evaluated the superresolution gene expression with the immunofluorescence staining for the same geneprotein pair obtained from the same tissue section in the IDC dataset, which includes
immunofluorescence staining for CD3ε, a T cell co-receptor that is involved in activating
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both the cytotoxic T cell and T helper cells. An accurate super-resolution gene expression
imputation approach should yield gene expression that correlates with the protein
expression obtained from immunofluorescence staining [46]. We treated the protein
expression of CD3ε staining as the ground truth (Fig. 4.3c) and evaluated the enhanced
gene expression at the pixel level by comparing their similarity with the
immunofluorescence image. We utilized Structural Similarity Index (SSIM) [147], a
commonly used metric for measuring the similarity between two images, for evaluation.
SSIM ranges from -1 to 1 with a value of 1 indicating two identical images, 0 indicating
no structural similarity, and -1 indicating strong dissimilarity. As shown in Fig. 4.3d, the
SSIM between the protein staining image and the super-resolution CD3E gene image
from TESLA is 0.33, while the SSIM is only 0.08 for BayesSpace (Fig. 4.3e), presumably
due to its inability to fill in gene expression in the unmeasured tissue area.We also
compared TESLA with BayesSpace using root mean squared error and reached to a
similar conclusion.
4.3.2. Characterization of High-resolution Cellular and Molecular Spatial Structure of
Tumor
The tumor edge is considered as the tumor invasion front due to its strong invasive
ability and it has been reported that tumor edge has unique microenvironment and
distinct morphological, structural, and molecular features from that of tumor core, such
as the level of immune cell infiltration and compositions, vascular density, hypoxia
status, metabolic rate, etc. [141, 148]. The super-resolution gene expression images
generated by TESLA enables the detection and precise annotation of tumor edge, which
enables further exploration of the structural, cellular, and molecular differences in tumor
and TME cells between the primary tumor core and edge.
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To show that such analyses can advance our understanding of intra-tumor heterogeneity,
we first analyzed the CSCC dataset of the skin [43]. As reported in the original study, the
tumors include basal, cycling, and differentiating keratinocyte cell populations that are
similar to normal skin, and a tumor-specific keratinocyte (TSK) population. Therefore,
we identified the tumor region using nine TSK marker genes suggested in the original
study (NT5E, PTHLH, INHBA, LAMC2, MMP10, FEZ1, CD151, IL24, SLITRK6), plus
three commonly used marker genes (TOP2A, KIF1C, BUB1B). Utilizing these genes,
TESLA derived a meta gene that captured all their patterns and further detected the
tumor region by joint segmentation of the meta gene and histology images. Fig. 4.4a
shows that the tumor region detected by TESLA agrees well with the dark region in the
histology image except the upper right and bottom right regions. Further examination of
the histology image of the upper right region by a pathologist (E.B.L.) revealed that this
region consists of dead cells with hypereosinophilic cytoplasm and pkynotic nuclei
(yellow box). This is further confirmed by the relatively low total unique molecular
identifier (UMI) counts compared to other regions. The region on the right represents
non-neoplastic skin adjacent to the squamous cell carcinoma (blue box). This example
shows that by combining gene expression and histology image together, TESLA can
accurately annotate live tumor region from non-viable or non-neoplastic tissue without
the reliance on a pathologist’s manual annotation.
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Figure 4. 4: TESLA characterizes intra-tumor heterogeneity in a CSCC sample and a melanoma sample.
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The leading edge drawn by TESLA also agrees well with pathologist’s manual annotation
(Fig. 4.4b). After detecting the tumor boundary, TESLA further separated the tumor into
core and edge (Fig. 4.4c). The tumor edge is defined as the area that is within 200 µm
interface of tumor and adjacent non-malignant tissue and the tumor core is defined as
the proximal tumor area within the tumor edge [141]. DEG analysis between the tumor
core and edge identified genes that are highly enriched in the core (3,665 genes) or edge
(106 genes). For example, in Fig. 4.4d, oncogenes such as IGFBP2, CCNB1, KRT15 and
HRAS are highly expressed in the core region, whereas tumor edge enriched genes
included CXCL12, IL2RB, LAIR1, and LILRB2, which are immune-related, implying a
distinct microenvironment from that of the tumor core. We further performed gene set
enrichment analysis for the 106 tumor edge enriched genes and the top 300 tumor core
enriched genes with the highest fold changes, by computing overlaps with curated gene
sets in the Molecular Signature Database [149]. Our analysis suggested significant
enrichment of the metabolism of lipids under hypoxic conditions and mitotic phase in
cell cycle in the tumor core. The high proliferation rate of cancer cells in the tumor core
leads to hypoxia and nutrient deprivation, which affect the lipid metabolism of cells[150,
151]. Pathways that are highly activated in the tumor edge included innate immune
system, adaptive immune system, interferon-g response, inflammatory response, and
cytokine signaling. These highly activated immune systems in the tumor edge are
possibly due to a higher level of immune cell density and tumor-immune interactions in
the edge. Together, TESLA’s unique feature to characterize and profile tumor edge and
core may provide great insights into better understanding of the TME and the
mechanisms of immune suppression and evasion.
To show the generalizability of TESLA in characterizing the cellular and molecular
spatial structure of tumor, we next analyzed the cutaneous malignant melanoma
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dataset[40]. Using a list of genes for clinical melanoma diagnosis [152] (MITF, CSPG4,
MAGEA1, MLANA, TYR and SOX10), TESLA identified the melanoma region, which
strongly recapitulate the pathologist’s manual annotation in Fig. 4.4e. Following similar
steps as described previously, we further separated the tumor region into tumor core and
edge (Fig. 4.4f), and detected 3,510 genes enriched in the tumor core and 155 genes
enriched in the tumor edge. Some hypoxia related genes [153, 154] (e.g., HSPB1, MIF,
TPI1) were detected to be highly expressed in the tumor core while most genes highly
expressed in the tumor edge are immune related (Fig. 4.4g). Next, we performed gene set
enrichment analysis for the 155 edge enriched genes and the top 300 core enriched genes
with the highest fold changes. Interestingly, for the top 300 core enriched genes, we
observed a significant upregulation of the signaling by Rho GTPases, receptor tyrosine
kinase, and Wnt, and MET activates RAS signaling, which are known to be involved in
melanoma progression through regulating cell proliferation and invasion [155, 156]. In
addition, we observed increased signaling by MET, which has emerged as a paradigm of
tumor resistance to modern targeted therapies, and the assessment of its expression in
patients' samples may be a valuable biomarker of tumor progression and response to
targeted therapy [157]. The enriched genes in the tumor edge are largely related to
inflammatory response, such as PDCD1, IL10RA, PAX5, CCL19, TNFSF4, IFI27, IL32,
and IL4R. Consistently, pathway enrichment analysis revealed increased expression of
interferon gamma response, cytokine signaling and cytokine-cytokine receptor
interaction, and increased signaling by Interleukins, suggesting activated anti-tumor
immune response. Interestingly, we also observed up-regulated expression of genes
defining epithelial-mesenchymal transition (EMT). EMT is a process through which
epithelial tumor cells acquire mesenchymal phenotypic properties, and it contributes to
both metastatic dissemination and therapy resistance in cancer [158]. The cell type
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distributions inferred by cell type deconvolution analysis with RCTD [159] also showed
significant difference between the tumor edge and core, with the tumor edge enriched for
T cells whereas the core enriched for malignant cells. We also demonstrate that all these
findings, based on the super-resolution annotation, cannot be achieved with the original
spot-level data.
4.3.3. Identification of Lymphoid Cell Types and TLS
Next, we show that TESLA can profile the spatial distribution of different immune cell
subsets based on super-resolution expression images of lineage-specific genes. We first
analyzed the CSCC data [43]. Using canonical cell type marker genes, we detected the
locations for B cells, CD4+ T cells, dendritic cells, and CXCL13, a marker of TLS that is
known to be also constitutively expressed in secondary lymphoid tissue. As shown in Fig.
4.5a, TESLA’s cell type distribution has much higher resolution than results obtained
from spot-level gene expression by SpaGCN [47], a clustering method developed for
spatial transcriptomics data (Fig. 4.5b). For Spatial Transcriptomics and Visium data,
each spot may contain multiple cells. By leveraging high-resolution histology image data,
TESLA’s cell type annotation achieves pixel-level resolution, which better describes the
underlying cell type distributions. By colocalizing B cells, CD4+ T cells, dendritic cells,
and CLCX13 near the tumor region, TESLA further detected TLSs (Fig. 4.5c).
Examination of the histology image by a pathologist (E.B.L.) indicates that the blue
boxed region contains aggregates of lymphocytes consistent with a TLS on the edge of
the tumor. We also observed the colocalization of lymphocytes in the yellow boxed
region that are not forming tight aggregated groups compared to the blue boxed region.
We suspect that these lymphocytes are collecting in this region but are not forming a TLS
due to geospace’s constraint of the tissue, or perhaps that this region represents the edge
of a TLS, which is not present due to the relative thinness of histologic images. TLS is an
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ectopic lymphoid formation within nonlymphoid tissue. TLS can additionally foster
tumor antigen presentation and T cell activation and the presence of TLS has been
associated with improved response to cancer immunotherapy and prolonged patient
survival [160-162]. Similar analysis was performed on the cutaneous malignant
melanoma data [40] using canonical cell type marker genes. We further validated the cell
type distribution by TESLA in Fig. 4.5a,d by performing cell type deconvolution analysis
using RCTD with annotated single-cell RNA-seq data from Ji et al. [43] and Tirosh et al.
[120] as the references. The deconvolution results revealed similar distribution and
density for B and T cells as predicted by TESLA. These results also demonstrate that by
utilizing known marker information, TESLA can infer cell subtypes without the reliance
on single-cell reference, which is advantageous compared to reference-based
deconvolution methods.
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Figure 4. 5: TESLA identifies lymphoid cell types and TLS with pixel-level resolution in the CSCC and
melanoma samples.
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Fig. 4.5e shows TLS density predicted by TESLA. Aggregations of lymphocytes are
observed at the bottom and the right side of the melanoma region, indicating strong
immune activity in the yellow and blue boxes, where we observed co-localization of B
cells, CD4+ T cells, and dendritic cells with a high expression of CXCL13 (Fig. 4.5d).
Since the top-region in the green box is not adjacent to tumor region but with aggregated
lymphocytes, it is annotated as a lymph node instead of a TLS. These results highlight
the importance of maintaining spatial relationships of gene expression in heterogeneous
tissue as the gene signature of TLS versus normal reactive lymph nodes are highly
similar, reflecting the formation of lymph-node like architecture of TLS’s associated with
tumors. By identifying the neoplastic tissue core and edge (Fig. 4.4f), together with the
TLS signature (Fig. 4.5e), TESLA can segment tumor associated TLS versus adjacent
non-neoplastic lymph node, which would have been lost in dissociated or homogenized
tissue analyses such as single-cell transcriptomics. The presence of TLS was further
validated by the location of follicular helper T cells, which is known to be present in
TLSs.
In addition to the CSCC and cutaneous malignant melanoma data, we also analyzed a
dataset [145] that has manual annotation and immunostaining validated TLS
information. This dataset was obtained from human clear cell renal cell carcinoma
(ccRCC) primary tumors, where the TLSs were manually annotated by pathologists and
further validated by triple immunofluorescence labeling (CD20/CD3/PD-1) on an
immediately adjacent slide for frozen samples and CD3/CD20 labeling by
immunohistochemistry for Formalin-Fixed Paraffin-Embedded (FFPE) samples. We
performed TLS detection using TESLA on a tissue section in this dataset. As shown in
Figure 4.5f, the TLS scores agree well with the two validated TLS regions, which further
demonstrates TESLA’s ability to correctly locate the TLSs.
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4.3.4. Detection of Cancer Subtypes in Breast Cancer
Next, we show that integration of gene expression and histology information can help
infer cancer subtypes. We first analyzed a HER2+, ER+ and PR- breast cancer dataset
generated by 10x Genomics [163]. Fig. 4.6a summarized the cancer subtypes
distribution, which is concordant with the diagnosis. We next analyzed an annotated
HER2+ human breast cancer dataset from Andersson et al. [144]. We selected three
patients H, G, and B and analyzed one tissue section from each patient. All three patients
are HER2 positive and ER negative, and only Patient B is PgR positive while the other
two are PgR negative. Based on the expression of basal markers such as KRT5, KRT7,
KRT14, and KRT18, and breast cancer markers previously reported, e.g., ERBB2,
GATA3, PIP, and SCGB2A2, TESLA detected the tumor region, demonstrating
concordance with manual annotation from the original study (Fig. 4.6b).
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Figure 4. 6: TESLA detects subtypes of breast cancer samples.
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Next, based on specific marker gene expression, we detected the HER2+, ER+ and PgR+
regions within the tumor for each tissue section. Fig. 4.6b-d summarized the cancer
subtypes distribution and the percentages of area for HER2, ER, and PgR for the three
tissue sections. We observed high expression of ERBB2, which encodes HER2, in the
tumors of all 3 patients, presented in 76%, 94%, and 76% of tumor cells, respectively, for
patients H, G, and B, confirming the diagnosis of HER2+ cancers. In addition, we
detected the expression of ER and PgR in patient B (Fig. 4.6d), and low-level expression
(0%-3%) of ER and PgR in the tumors of patients H and G, indicating the high degree of
intratumoral heterogeneity in these tumors, owing to the super-resolution gene
expression images generated by TESLA. For patient B, although it is diagnosed to be ERand PR+, we detected 33.6% of the tumor cells to be ER+ and only 20.0% of the tumor
cells to be PR+. We contacted the authors of the original paper and they claimed that the
cancer subtype classifications were based on IHC (and PAM50) on a separate piece of the
tumor. The low proportion of PR+ tumor cells and relatively high proportion of ER+
tumor cells may be due to the difference in hormone receptors between the piece used
for the Visium experiment and the piece used for IHC. These results demonstrate the
power of TESLA in quantitative evaluation of tumor subtypes and the additional
information it provides that is beyond the simple positive or negative annotation of a
tumor.

4.4. Discussion
In this chapter, we presented TESLA, a machine learning framework for multi-level
tissue annotation on the histology image with pixel-level resolution in ST. By integrating
information from high-resolution histology image, TESLA can impute gene expression at
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superpixels and fill in missing gene expression in tissue gaps. The increased gene
expression resolution makes it possible to treat gene expression data as images, which
enabled the integration with histological features for joint tissue segmentation and
annotation of different cell types directly on the histology image with pixel-level
resolution. Additionally, TESLA can detect unique structures of tumor immune
microenvironment such as TLS, separate a tumor into core and edge to examine their
cellular compositions, expression features, and molecular processes. TESLA has been
evaluated on five cancer datasets, including cutaneous squamous cell carcinoma of the
skin [43], cutaneous malignant melanoma [40], and three breast cancer datasets [146,
163, 164]. Our results consistently showed that TESLA can generate high-quality superresolution gene expression images, which facilitated the downstream multi-level tissue
annotation.
Hematoxylin and eosin-stained histology images are routinely used in clinics for disease
diagnosis. Utilizing manual annotation of histology images provided by pathologists,
supervised methods have been developed to computationally annotate tissues; for
example, Saltz et al. [165] developed a deep learning model focusing on detecting TIL
using histology images in The Cancer Genome Atlas Program. However, these supervised
methods require large, well-labelled training data in which expert pathologists are
demanded to review a large set of images and mark detailed regions of lymphocytes and
necrosis. Although pathologists’ annotation is highly effective for disease diagnosis, it is
qualitative and prone to both inter- and intra- observer variability, particularly when
quantifying or characterizing feature-rich phenomena such as tumor-associated
lymphocytic infiltrates. Additionally, existing supervised methods only utilize histology
information, which limit their usefulness in studying detailed structure in TME as
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histology alone cannot reveal subtypes of lymphocytes but can be distinguished using
gene expression.
The cell type annotation in TESLA shares similarity with traditional clustering-based cell
type annotation, but TESLA has several advantages. First, TESLA’s annotation has much
higher resolution than annotation obtained from spot-level gene expression clustering.
Second, in traditional clustering, each spot is assigned to a single cell type. However, for
spatial barcoding-based ST data, e.g., Spatial Transcriptomics and 10x Visium, each spot
may contain multiple cells. Although deconvolution-based methods such as RCTD [56]
and RCTD [159] can infer cell type proportions within each spot, they cannot tell the cell
identity for each cell within the spot. By contrast, through leveraging high-resolution
histology image information, TESLA’s annotation can provide cell type enrichment
information with pixel-level resolution. Additionally, deconvolution-based methods
require an annotated single-cell reference [54-56, 166], which would limit their
applications when single-cell references are not available.
In this chapter, we only showed examples of combining histology and gene expression
for cell type annotation, but it is also possible to incorporate immunofluorescence
images for cell-type-specific proteins to infer targeted cell types using TESLA. Although
immunofluorescence images can be used directly to infer cell identity for each cell,
artifact in the images may render the results less reliable. When analyzing the CD3ε
immunofluorescence data, we noticed the light in the original CD3ε immunofluorescence
image is not flat across the tissue area, leading to brighter staining in the upper part and
darker staining in the lower part of the tissue (Fig. 4.3c). This uneven illumination
results in an inaccurate estimation of CD3ε abundance. By combining the gene image for
CD3E and the CD3ε immunofluorescence image into a 2-channel image as input, TESLA
inferred the distribution of T cells. We noticed that the upper edge now has lower degree
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of T cell enrichment, suggesting that combining gene expression and
immunofluorescence image can correct immunofluorescence image artifact.
Although we illustrated the application of TESLA in cancer, the framework is generic and
can be applied to other medical conditions as long as high-resolution histology images
are available. We also demonstrate that TESLA is computationally fast and memory
efficient compared to BayesSpace. With the increasing popularity of ST in biomedical
research, we expect TESLA will be an attractive tool for ST data analysis. Results from
TESLA will enable researchers to increase gene expression resolution and annotate their
tissues of interest with high confidence.
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Chapter 5: Outlook and future research directions

In this dissertation, I proposed a series of statistical and machine learning methods to
address challenges in single cell and spatially resolved transcriptomics data analyses.
The field of genomics has now moved toward generating data with more complex
structures. When building spatially resolved molecular atlases of brains, e.g., Allen Brain
Atlas, or whole organs, such as in the Human Cell Atlas [167], multiple tissue samples
from several subjects and multiple tissue sections per subject will be generated. Such
complex data structure poses computational challenges. Effective modeling of such data
requires new methods that can account for the spatial dependency of gene expression in
the 3D space, gene expression variability driven by spatial differences associated with
biological variables such as sex, age, race, and body size. To account for these factors, the
gene expression data from tissue sections across different individuals need to be
registered to a common coordinate framework. After the gene expression data are
registered, methods that can account for variations across space and individuals can be
utilized to identify marker genes that define the transcriptional landmarks. There will be
greater need for more powerful and efficient methods for the analysis of multiple tissue
sections across different subjects in the next few years.
As the resolution of histology images in SRT data is much higher than that of the
companion gene expression data, an ideal approach should be able to effectively
integrate histology information in the analysis. Although progress has been made in
integrating histology and gene expression, current methods mainly focus on the global
pattern in histology images while the more granular information, e.g., the morphology of
the nucleus in each spot, is ignored. Nuclei segmentation in histopathology images is
routinely done for pathology diagnosis [168, 169]. However, such information has only
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been utilized to verify results after gene expression data are analyzed, but not directly
used in the analysis [42]. Information on the number of nuclei per spot and the
associated morphology of each nucleus is invaluable in cell-type deconvolution because it
can tell us how many cells and cell types are present in a spot. A deconvolution method
that takes this detailed information into account will be able to infer cell-type
proportions in each spot more precisely than existing methods, which in turn will also
help estimate cell-type-specific gene expression. With these more accurate deconvolution
results, we can get a better understanding of cell-cell communications and how they vary
by spatial proximity. However, as the SRT technology keeps evolving, some spatial
transcriptomics sequencing methods can measure transcripts at single-cell or even
subcellar level [170, 171]. When these methods become commercialized, deconvolution
will no longer be an issue in this area.
Batch effect is a common issue in the analyses of scRNA-seq data. Many methods have
been developed for batch effect removal for scRNA-seq [116, 172]. In SRT, the batch
effect is even more complex, particularly for SRT data that have companion histology
images in which batch effect can affect both gene expression and histology images across
different tissue sections, subjects, and studies. This is still an unexplored area, but I
envision that batch effect correction will become an important problem as the scale of
SRT increases. Methods to evaluate and remove batch effects in both gene expression
and histology images are needed.
The understanding of cellular behavior within spatial context is critical to our
understanding of human disease. Although histopathology is the clinical gold standard
for the diagnosis of many diseases, interpretation of histology is still an art that makes
pathologists essential for accurate disease diagnosis. In some cases, e.g., rare diseases,
the histological assessment may be subject to diagnostic uncertainty due to the lack of
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knowledge of pathological changes. This uncertainty can be alleviated by expression
information on genes with well-defined functions. The gene expression data, together
with high-resolution histology images in these new spatial technologies, will help deepen
our understanding of what is happening in tissue, which will be applicable to most areas
of biomedical research. Since histology image and gene expression data provide
complementary information, it will be desirable to have methods that can incorporate
the pathologist’s annotation as prior information in the analysis.
SRT only assess microorganism at the RNA level. As the concept of multi-omics becomes
more and more popular, many studies have started to generate data of other modalities
together with RNA sequencing to better decipher the tissue microenvironment. For
example, proteomics is able to directly measures the protein abundance across the tissue
but can only target a limited number of proteins. Mass spectrometry-based
metabolomics data can simultaneously quantify multiple small molecule types, such as
amino acids, fatty acids, carbohydrates, or other products of cellular metabolic functions,
which are usually involved in cellular interactions. By integrating the multi-omics data,
both newly generated and publicly available, we will have a comprehensive
understanding of the biological mechanism that empowers precision therapeutic
targeting of a broad array of complex human diseases.
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